data_2eqw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eqw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.622 0.725 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.23 105.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.78 115.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 40.3 t -53.12 127.2 23.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 70.6 p -96.54 31.46 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -125.86 -42.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.35 -33.11 3.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.07 86.19 1.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -158.06 124.92 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.07 143.92 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.053 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -133.18 97.14 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.85 -27.78 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -90.66 162.4 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -107.64 40.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 57.4 p -133.55 -54.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -72.37 -53.61 11.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.65 -37.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.5 m -74.95 -27.65 60.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.68 -25.35 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -68.35 -25.56 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -63.87 -60.46 3.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.8 tt -53.18 -28.34 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.613 0.721 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.22 107.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 81.4 t -107.9 129.87 61.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 53.1 t -70.48 130.1 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 69.9 p -95.96 37.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -128.5 -41.08 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 16.8 p -123.1 -36.59 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.76 80.65 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -151.87 128.28 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -88.84 143.49 26.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -130.99 99.21 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.61 -37.73 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -88.13 152.25 22.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -96.03 42.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.9 p -131.77 -44.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -67.98 -26.59 66.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.86 -51.43 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.73 -32.55 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -82.79 -28.29 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -67.84 -24.49 65.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -69.38 -24.5 63.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -59.34 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 tt -53.11 -28.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.274 . . . . 0.0 112.345 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.19 106.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.86 122.41 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.5 t -52.83 127.77 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 28.8 p -95.45 27.82 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -130.2 -45.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 22.0 p -116.69 -26.75 6.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.14 79.36 1.43 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.81 116.17 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.324 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.18 140.66 30.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.42 100.99 4.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -53.24 -29.68 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.45 168.96 13.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -111.02 26.88 10.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 96.1 p -125.06 -50.08 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -59.29 -36.11 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.42 -57.29 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.82 -51.62 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -65.66 -25.69 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -75.74 -19.26 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.44 -23.05 43.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -59.01 -45.94 89.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 13.9 tt -51.61 -30.02 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.29 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.25 106.61 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.75 119.78 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.7 t -52.07 124.66 13.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 73.3 p -95.52 31.78 1.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.43 -43.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.67 -28.92 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 94.11 84.4 1.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -156.44 124.71 5.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.92 141.54 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.17 101.19 5.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.14 -35.49 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -80.83 157.18 25.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -102.09 26.03 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.9 t -125.69 -49.6 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.28 -34.93 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -63.08 -59.54 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.75 -48.42 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 30.1 m -65.74 -31.57 72.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.07 -18.33 60.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -79.53 -23.3 42.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 32.6 mtp85 -58.96 -46.18 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.0 tt -53.6 -27.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -166.27 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.286 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.3 106.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.79 131.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.48 126.59 28.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 31.8 p -95.52 28.07 3.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -129.72 -45.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.23 -28.17 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.0 84.83 1.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -157.36 127.8 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.28 28.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.97 100.19 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.95 -31.0 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 40.7 mtm-85 -82.54 154.91 24.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -103.24 26.08 8.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 6.9 t -129.44 -40.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.42 -29.83 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.66 -52.83 22.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.63 -35.86 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.3 m -83.3 -25.54 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -18.21 63.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.06 -22.95 44.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -59.6 -45.88 90.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.0 tt -55.88 -25.02 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.2 mttp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -166.27 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.393 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.25 106.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 87.8 t -103.7 133.61 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.95 126.97 31.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 18.1 p -96.59 29.99 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.01 -43.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.87 -31.36 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 98.64 85.3 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.471 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -157.92 128.55 6.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.3 26.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.84 103.17 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.47 -31.06 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -80.31 163.86 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -109.49 29.2 7.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 48.0 t -123.93 -61.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -52.56 -42.43 64.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.4 -49.98 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.9 mt -67.41 -32.39 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -94.34 20.43 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -116.35 -18.63 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.6 -23.48 42.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -58.6 -46.3 87.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -52.24 -29.24 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.58 0.705 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.22 111.61 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 79.0 t -110.22 118.96 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 34.3 t -55.37 130.76 43.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 23.3 p -99.81 29.06 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -127.2 -43.8 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 30.9 p -117.03 -28.34 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.76 87.09 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -160.11 127.38 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.22 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.54 101.15 4.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.28 -32.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -79.21 152.07 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -102.01 26.44 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 t -125.38 -46.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.69 -27.95 68.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -70.24 -51.23 32.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.93 -31.36 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.9 m -88.38 -25.12 22.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -71.99 -16.55 62.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.13 -23.6 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -45.04 95.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.79 -25.11 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.535 0.683 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.23 106.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.97 123.36 56.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 17.8 t -58.25 125.51 23.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.3 p -95.91 29.79 2.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -126.31 -46.37 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.8 p -116.88 -28.56 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.32 86.92 1.78 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -160.11 125.67 4.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.56 145.69 27.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.17 102.18 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.7 mt -58.72 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 27.7 mtm-85 -86.71 150.81 23.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -96.87 26.37 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.1 p -125.81 -48.46 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.06 -33.23 72.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.84 -57.46 8.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.18 -48.78 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.4 m -67.37 -25.44 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -79.64 -16.73 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.99 -23.38 38.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -61.76 -44.98 95.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -56.08 -24.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.862 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.2 105.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 86.5 t -103.16 118.66 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.5 t -57.73 125.73 24.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 60.1 p -95.61 28.51 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -123.15 -44.96 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.8 -30.03 5.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 97.28 82.47 1.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -157.45 129.77 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.335 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -91.11 141.54 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.075 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -130.17 102.9 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.81 -27.13 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -84.77 152.37 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -101.9 26.24 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 72.4 p -125.62 -46.68 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.83 -26.3 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -71.69 -48.48 47.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.26 -29.66 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.1 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -90.27 -25.17 20.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -69.67 -16.7 63.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -81.05 -23.22 38.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -61.97 -44.85 95.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -56.06 -24.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 26.2 mttp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -166.29 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.315 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.25 104.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.66 120.92 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.87 126.68 28.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 71.6 p -95.69 25.35 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -121.98 -40.65 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 24.4 p -118.62 -31.78 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.14 79.56 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -155.63 130.77 9.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.4 146.96 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.03 100.21 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.35 -25.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 144.38 30.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -96.62 26.01 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 4.9 m -131.69 -40.74 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.01 -33.13 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.3 -56.66 10.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.7 -45.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -71.49 -33.92 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -66.8 -16.55 64.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.06 -23.51 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -61.59 -45.15 95.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.06 -24.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.572 0.701 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.673 2.249 . . . . 0.0 112.317 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.16 104.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.06 120.78 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.38 126.59 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 17.7 p -96.82 31.69 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -132.3 -44.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.2 p -114.16 -28.85 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.44 82.92 1.49 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -156.91 130.01 7.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.68 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -137.02 100.64 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.32 -25.59 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -81.85 148.59 28.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -99.88 25.87 6.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 75.1 p -131.6 -41.36 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -67.66 -34.17 76.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -66.18 -55.52 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -52.48 -42.46 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.0 m -73.84 -33.92 64.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.87 -17.1 63.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.75 -22.62 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -62.66 -44.73 95.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -56.41 -24.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 29.1 mttm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.662 2.242 . . . . 0.0 112.332 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.25 105.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 66.3 t -99.84 141.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.3 t -78.08 128.09 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -95.59 27.87 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -127.96 -42.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.5 p -117.62 -30.3 5.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.59 80.94 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.529 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -154.64 130.17 9.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.39 26.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.86 98.08 3.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.68 -25.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -84.07 156.1 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 31.66 4.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 87.3 p -138.5 -44.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.49 -27.17 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -74.19 -57.57 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.5 mt -51.93 -41.0 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.5 m -74.94 -27.5 60.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -74.76 -16.77 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.61 -23.16 39.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -62.14 -45.09 94.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -57.11 -23.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.523 0.677 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.27 104.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 66.8 t -103.35 132.15 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.61 127.95 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.2 p -95.98 25.07 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -120.77 -46.32 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.99 -29.22 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 95.61 81.18 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -153.68 127.93 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.46 148.15 25.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.28 100.24 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.26 -34.53 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -82.58 155.47 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -103.78 36.43 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.1 t -132.51 -45.88 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -68.03 -28.11 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -70.83 -51.04 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.48 -32.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.4 m -87.21 -25.14 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -70.95 -16.86 62.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -80.48 -22.97 40.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -62.46 -44.96 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -57.75 -22.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.849 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 37.5 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.538 0.685 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -166.29 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.376 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.21 104.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 93.3 t -102.88 116.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.98 130.78 30.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 81.3 p -95.13 25.0 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -122.96 -35.85 2.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.8 p -119.52 -40.44 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.48 42.52 1.59 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.68 136.25 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.328 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -93.6 146.31 23.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -135.38 101.74 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.79 -35.87 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 26.76 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.5 t -125.03 -46.23 1.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -62.27 -35.88 80.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -61.65 -55.11 34.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.98 -51.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -66.72 -25.11 66.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -77.72 -16.64 58.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.48 -23.33 40.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -62.19 -45.18 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -57.63 -23.0 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.915 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.571 0.701 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -166.32 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.24 105.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.25 114.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 9.0 t -52.03 130.7 30.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 74.0 p -95.23 25.16 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -122.75 -35.8 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.45 -40.79 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.99 43.78 1.36 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.11 134.38 55.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -95.31 147.88 23.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -135.64 99.72 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.03 -30.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -81.07 174.43 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -120.93 25.97 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.2 m -125.53 -45.19 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -64.24 -27.86 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -70.43 -56.53 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.71 -32.45 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -88.12 -25.03 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.48 -16.72 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -80.34 -23.44 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -62.09 -45.23 94.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -57.9 -22.67 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.841 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.592 0.711 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.37 107.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 83.2 t -108.26 116.08 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.121 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 25.8 t -52.1 127.02 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 22.5 p -95.24 25.96 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -121.88 -48.64 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.27 -26.44 8.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.29 81.98 1.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -151.21 124.75 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.96 141.83 28.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -134.58 103.24 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.5 -37.15 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -78.24 162.94 26.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -110.18 31.65 5.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.2 p -126.49 -50.06 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.92 -27.66 68.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -70.46 -54.74 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.72 -33.37 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 90.9 m -86.7 -25.1 24.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -71.95 -17.22 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.21 -22.43 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -63.17 -44.75 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 11.9 tt -58.13 -22.23 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.867 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.566 0.698 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -166.31 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -50.46 109.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 99.5 t -105.83 117.93 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.14 137.16 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.8 p -95.41 26.81 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.62 -40.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.5 -28.99 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.09 30.05 9.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -95.6 138.6 33.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -92.1 141.7 28.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -127.77 90.53 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 76.9 mt -51.78 -29.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -85.89 164.38 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -111.36 28.24 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 m -128.68 -39.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -71.56 -28.14 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.1 -44.47 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.8 mt -65.42 -27.62 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -90.53 -25.07 20.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.54 -23.93 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -70.37 -24.86 63.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -64.9 -59.27 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.6 tt -53.01 -28.42 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.587 0.708 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.667 2.244 . . . . 0.0 112.41 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.26 104.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.36 124.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 11.2 t -60.52 127.49 31.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 19.0 p -96.18 29.48 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.77 -47.11 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.74 -27.2 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.16 82.7 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -156.18 128.07 7.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.11 146.61 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.56 100.71 4.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.27 -33.03 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -83.24 152.76 25.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -99.28 27.11 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.6 t -124.73 -49.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.28 -40.22 85.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -57.36 -54.44 46.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.83 -55.2 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -61.22 -25.56 67.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.169 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -80.43 -17.61 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -79.71 -21.72 44.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -63.97 -44.92 91.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -58.73 -21.54 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.52 0.676 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.661 2.241 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.25 109.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 63.7 t -105.64 124.32 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.197 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.4 t -60.15 127.45 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 43.9 p -95.33 25.2 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.19 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -124.09 -46.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.2 p -113.24 -27.25 8.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.846 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 90.41 78.86 1.35 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -151.63 132.49 14.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.31 148.36 26.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.02 95.87 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.84 -27.17 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -83.84 155.95 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.62 32.72 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.7 p -139.89 -45.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.16 -28.33 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.57 -55.21 5.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.18 -32.5 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 91.9 m -84.66 -26.36 27.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -74.36 -17.96 60.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.82 -22.88 52.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.43 -19.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.544 0.687 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -166.26 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -50.36 110.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 70.4 t -104.84 131.82 53.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.5 128.48 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 51.3 p -95.99 25.11 4.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -126.97 -44.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.13 -26.88 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 88.92 84.41 1.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -154.68 123.8 6.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -77.57 144.79 37.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -135.24 96.88 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.57 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -84.32 159.29 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.09 24.79 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.0 p -134.26 -44.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -60.46 -26.72 66.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -78.26 -56.34 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.6 mt -54.34 -30.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 93.6 m -85.13 -25.56 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -82.33 -18.23 42.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -78.52 -23.04 46.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -59.63 -45.49 91.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.0 tt -57.29 -23.3 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 27.7 m -132.41 58.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.357 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.5 m -102.51 33.02 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.09 -81.71 1.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 m 59.43 46.03 12.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.6 m -143.86 157.34 44.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.85 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.63 53.77 4.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.65 118.5 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.957 0.408 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -94.39 160.71 31.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.23 105.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.78 115.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 40.3 t -53.12 127.2 23.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 70.6 p -96.54 31.46 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -125.86 -42.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.35 -33.11 3.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.07 86.19 1.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -158.06 124.92 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.07 143.92 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.053 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -133.18 97.14 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.85 -27.78 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -90.66 162.4 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -107.64 40.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 57.4 p -133.55 -54.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -72.37 -53.61 11.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.65 -37.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.5 m -74.95 -27.65 60.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.68 -25.35 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -68.35 -25.56 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -63.87 -60.46 3.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.8 tt -53.18 -28.34 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -79.17 -64.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 78.0 p -55.87 103.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -64.04 -35.53 92.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.509 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -123.81 134.71 53.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 5.3 t -173.01 120.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.11 27.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -40.39 5.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 53.7 p -60.36 -36.99 79.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.3 p -96.44 147.49 23.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.501 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.7 t -112.56 86.22 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.905 0.383 . . . . 0.0 110.864 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 16.9 t -98.69 -52.46 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.883 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.62 174.15 54.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.2 p -151.13 108.78 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 110.817 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 -56.91 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -102.78 165.1 16.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -169.89 150.92 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -87.2 160.65 48.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.22 107.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 81.4 t -107.9 129.87 61.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 53.1 t -70.48 130.1 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 69.9 p -95.96 37.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -128.5 -41.08 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 16.8 p -123.1 -36.59 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.76 80.65 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -151.87 128.28 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -88.84 143.49 26.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -130.99 99.21 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.61 -37.73 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -88.13 152.25 22.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -96.03 42.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.9 p -131.77 -44.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -67.98 -26.59 66.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.86 -51.43 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.73 -32.55 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -82.79 -28.29 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -67.84 -24.49 65.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -69.38 -24.5 63.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -59.34 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 tt -53.11 -28.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -81.09 -42.2 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 74.2 p -85.42 84.1 7.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -104.87 75.34 0.24 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -134.07 41.07 3.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.902 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 18.9 m -115.33 52.55 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -84.54 170.21 46.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 146.03 59.5 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.382 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 t 52.55 50.7 17.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 p -128.12 162.91 25.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.488 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 8.1 t 62.36 31.61 17.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.84 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 72.4 m -114.58 -66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.59 66.71 1.01 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.5 t -68.98 134.13 49.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.832 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 3.2 m -61.8 167.44 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -138.66 144.39 15.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.521 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.14 27.9 8.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.896 0.379 . . . . 0.0 110.864 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -98.82 160.64 27.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.505 0.669 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.274 . . . . 0.0 112.345 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.19 106.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 92.2 t -109.86 122.41 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.5 t -52.83 127.77 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 28.8 p -95.45 27.82 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -130.2 -45.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 22.0 p -116.69 -26.75 6.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.14 79.36 1.43 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.81 116.17 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.324 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.18 140.66 30.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.42 100.99 4.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -53.24 -29.68 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.45 168.96 13.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -111.02 26.88 10.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 96.1 p -125.06 -50.08 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -59.29 -36.11 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.42 -57.29 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.82 -51.62 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -65.66 -25.69 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -75.74 -19.26 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.44 -23.05 43.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -59.01 -45.94 89.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 13.9 tt -51.61 -30.02 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -89.1 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 39.9 p -52.12 -62.97 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 137.93 -73.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.425 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -169.4 110.14 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.8 m -101.48 69.87 1.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.818 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.45 175.76 7.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 105.09 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.9 t -69.35 112.33 5.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 14.5 t -110.03 74.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-O 119.112 -0.826 . . . . 0.0 112.506 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.4 m -117.37 93.18 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.809 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.1 m -164.44 162.59 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 145.88 59.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 66.4 m -140.78 -179.59 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 59.8 p -157.07 154.73 29.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -170.33 81.69 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.15 176.68 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.404 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -132.54 160.73 67.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.29 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.25 106.61 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 91.7 t -103.75 119.78 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.7 t -52.07 124.66 13.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 73.3 p -95.52 31.78 1.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.43 -43.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.67 -28.92 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 94.11 84.4 1.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -156.44 124.71 5.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.92 141.54 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.17 101.19 5.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.14 -35.49 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -80.83 157.18 25.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -102.09 26.03 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.9 t -125.69 -49.6 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.28 -34.93 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -63.08 -59.54 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.75 -48.42 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 30.1 m -65.74 -31.57 72.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -75.07 -18.33 60.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -79.53 -23.3 42.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 32.6 mtp85 -58.96 -46.18 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.0 tt -53.6 -27.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -86.24 -41.05 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 73.6 p -66.36 -26.97 67.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -98.64 -86.5 1.87 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.26 170.6 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.363 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 58.8 m -95.66 -67.12 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -136.85 173.71 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.496 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -26.99 26.74 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 13.3 p -130.1 158.9 38.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 p -158.4 125.17 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.502 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 20.2 m -106.94 49.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.8 t -153.22 155.37 36.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -170.08 49.19 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 94.0 p -143.01 127.35 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 20.0 p -88.49 -27.02 21.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 111.76 -156.43 15.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -113.3 132.41 55.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 0.0 110.912 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -154.33 160.72 30.63 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -166.27 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.286 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.3 106.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.79 131.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.48 126.59 28.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 31.8 p -95.52 28.07 3.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -129.72 -45.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.23 -28.17 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.0 84.83 1.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -157.36 127.8 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.28 28.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.97 100.19 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.95 -31.0 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 40.7 mtm-85 -82.54 154.91 24.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -103.24 26.08 8.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 6.9 t -129.44 -40.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.42 -29.83 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.66 -52.83 22.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.63 -35.86 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.3 m -83.3 -25.54 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -69.36 -18.21 63.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.06 -22.95 44.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -59.6 -45.88 90.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.0 tt -55.88 -25.02 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -87.47 -30.78 20.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 71.5 p -81.64 78.27 8.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.16 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -96.68 67.05 0.95 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.441 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -113.98 55.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.877 0.37 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 t -121.81 -49.48 2.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -152.23 -72.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 115.45 4.1 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.696 2.264 . . . . 0.0 112.348 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.3 t -146.4 151.13 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 8.5 t -100.45 47.63 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 119.179 -0.789 . . . . 0.0 112.521 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 p -151.72 152.17 32.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.858 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 2.0 t -93.12 127.02 38.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -174.08 -59.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 m -116.44 133.52 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.883 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 1.4 t -115.32 -29.55 6.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 110.56 105.53 2.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -110.67 35.94 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -99.24 160.65 27.04 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.534 0.683 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -166.27 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.393 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.25 106.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 87.8 t -103.7 133.61 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.95 126.97 31.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 18.1 p -96.59 29.99 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.01 -43.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.87 -31.36 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 98.64 85.3 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.471 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -157.92 128.55 6.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.3 26.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.84 103.17 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.47 -31.06 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -80.31 163.86 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -109.49 29.2 7.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 48.0 t -123.93 -61.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -52.56 -42.43 64.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.4 -49.98 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.9 mt -67.41 -32.39 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.6 m -94.34 20.43 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -116.35 -18.63 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.6 -23.48 42.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -58.6 -46.3 87.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -52.24 -29.24 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -87.69 -47.51 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 66.5 p -74.28 74.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 173.04 74.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.33 175.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.34 59.52 5.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 104.25 69.14 0.77 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.71 15.93 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.733 2.288 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.9 m -65.78 99.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.5 t -113.15 143.11 44.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.49 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 t -58.04 140.62 52.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -95.65 90.25 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -83.2 -139.82 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 20.0 m -150.88 135.86 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.845 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 29.9 t -97.82 -51.81 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.68 145.25 5.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 101.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -117.13 160.66 36.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.58 0.705 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.22 111.61 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 79.0 t -110.22 118.96 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 34.3 t -55.37 130.76 43.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 23.3 p -99.81 29.06 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -127.2 -43.8 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 30.9 p -117.03 -28.34 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.76 87.09 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -160.11 127.38 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.22 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.54 101.15 4.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.28 -32.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -79.21 152.07 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -102.01 26.44 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 t -125.38 -46.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.69 -27.95 68.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -70.24 -51.23 32.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.93 -31.36 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.9 m -88.38 -25.12 22.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -71.99 -16.55 62.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.13 -23.6 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -45.04 95.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.5 tt -55.79 -25.11 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -95.51 -28.84 14.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 67.2 p -104.52 40.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -98.8 -50.89 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.51 157.47 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 73.6 m -93.79 44.12 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -165.38 69.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.41 11.02 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.9 t -117.92 119.47 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.6 p -78.44 -35.38 46.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.04 109.8 18.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.9 p -159.26 168.53 26.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 139.49 -159.03 25.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 73.8 p -151.12 115.91 5.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.837 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 60.1 p -96.41 33.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -176.07 -137.31 2.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -162.66 139.87 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -134.35 160.66 67.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.535 0.683 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.23 106.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.97 123.36 56.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 17.8 t -58.25 125.51 23.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.3 p -95.91 29.79 2.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -126.31 -46.37 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.8 p -116.88 -28.56 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.32 86.92 1.78 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -160.11 125.67 4.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.56 145.69 27.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.17 102.18 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.7 mt -58.72 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 27.7 mtm-85 -86.71 150.81 23.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -96.87 26.37 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.1 p -125.81 -48.46 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.06 -33.23 72.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.84 -57.46 8.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.18 -48.78 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.4 m -67.37 -25.44 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -79.64 -16.73 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.99 -23.38 38.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -61.76 -44.98 95.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -56.08 -24.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -94.36 -27.01 16.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 76.8 p -104.07 30.55 5.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -92.64 153.02 21.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.45 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -119.31 143.73 47.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.915 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.6 m 58.71 28.48 17.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -139.65 -74.61 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -17.21 37.69 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.622 2.215 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 110.66 20.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.81 -62.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.5 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.2 m -95.06 -51.92 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.4 m -83.13 178.42 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 101.52 160.95 27.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 61.7 m -97.82 82.92 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.856 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 18.6 m -113.78 -178.36 3.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 105.2 -94.72 1.03 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.534 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.95 45.37 18.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -134.79 160.7 67.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.388 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.2 105.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 86.5 t -103.16 118.66 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.5 t -57.73 125.73 24.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 60.1 p -95.61 28.51 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -123.15 -44.96 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.8 -30.03 5.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 97.28 82.47 1.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -157.45 129.77 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.335 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -91.11 141.54 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.075 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -130.17 102.9 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.81 -27.13 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -84.77 152.37 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -101.9 26.24 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 72.4 p -125.62 -46.68 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.83 -26.3 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -71.69 -48.48 47.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.26 -29.66 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.1 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -90.27 -25.17 20.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -69.67 -16.7 63.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -81.05 -23.22 38.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -61.97 -44.85 95.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -56.06 -24.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.35 -35.42 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 46.7 p -91.8 44.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.112 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -130.61 -162.05 10.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -129.81 48.76 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.863 0.363 . . . . 0.0 110.853 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.7 p -88.78 59.9 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -176.04 -171.36 39.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -48.18 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.7 m -60.68 132.61 54.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.2 p -121.56 -58.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.488 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.1 m -67.94 112.81 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.844 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.3 p -159.34 165.2 33.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 105.93 58.08 0.64 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 m -65.39 130.84 44.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 29.7 t -144.31 109.25 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -167.09 105.12 0.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -130.17 156.69 44.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -106.87 160.68 25.44 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.566 0.698 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -166.29 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.315 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.25 104.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.66 120.92 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.87 126.68 28.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 71.6 p -95.69 25.35 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -121.98 -40.65 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 24.4 p -118.62 -31.78 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.14 79.56 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -155.63 130.77 9.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.4 146.96 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.03 100.21 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.35 -25.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 144.38 30.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -96.62 26.01 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 4.9 m -131.69 -40.74 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.01 -33.13 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.3 -56.66 10.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.7 -45.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -71.49 -33.92 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -66.8 -16.55 64.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.06 -23.51 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -61.59 -45.15 95.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -56.06 -24.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -89.46 -28.6 19.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 75.2 p -95.6 69.14 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 177.33 -118.44 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.481 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.08 -53.54 5.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.0 t 62.97 49.55 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -153.24 69.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -33.88 15.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 7.7 p -88.8 -33.15 17.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 m 61.01 53.11 3.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.105 -0.831 . . . . 0.0 112.476 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 91.6 p -109.1 125.14 51.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.881 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 m -114.71 134.85 54.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 152.46 82.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.0 m -122.89 154.07 38.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 0.0 110.852 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.5 p -131.12 78.62 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -108.77 101.0 1.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.26 69.29 0.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -115.7 160.7 33.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.673 2.249 . . . . 0.0 112.317 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.16 104.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.06 120.78 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.38 126.59 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 17.7 p -96.82 31.69 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -132.3 -44.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.2 p -114.16 -28.85 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.44 82.92 1.49 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -156.91 130.01 7.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.68 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -137.02 100.64 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.32 -25.59 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -81.85 148.59 28.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -99.88 25.87 6.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 75.1 p -131.6 -41.36 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -67.66 -34.17 76.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -66.18 -55.52 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -52.48 -42.46 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.0 m -73.84 -33.92 64.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -69.87 -17.1 63.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.75 -22.62 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -62.66 -44.73 95.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -56.41 -24.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -92.33 -42.32 9.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 79.0 p -88.92 103.1 15.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 145.5 83.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.448 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.37 68.17 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 9.1 t -173.46 118.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -166.61 -173.52 35.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.497 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 -22.69 32.19 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.258 . . . . 0.0 112.368 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.3 p -54.44 131.73 42.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.9 p -131.35 79.51 1.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.481 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -95.03 -39.8 9.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.357 . . . . 0.0 110.882 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 83.7 p -62.14 -35.07 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -94.48 23.78 30.61 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.8 t -114.65 92.44 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.8 p -94.74 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 177.9 -165.88 35.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.539 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.45 57.34 3.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -106.09 160.73 25.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.86 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.662 2.242 . . . . 0.0 112.332 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.25 105.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 66.3 t -99.84 141.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.3 t -78.08 128.09 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -95.59 27.87 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -127.96 -42.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.5 p -117.62 -30.3 5.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.59 80.94 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.529 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -154.64 130.17 9.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.39 26.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.86 98.08 3.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.68 -25.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -84.07 156.1 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 31.66 4.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 87.3 p -138.5 -44.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.49 -27.17 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -74.19 -57.57 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.5 mt -51.93 -41.0 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.5 m -74.94 -27.5 60.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -74.76 -16.77 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.61 -23.16 39.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -62.14 -45.09 94.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -57.11 -23.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -89.02 -37.62 15.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 66.8 p -81.36 85.92 6.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -109.08 -170.62 20.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -121.13 27.11 8.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 30.6 t -54.21 -47.66 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -76.33 171.05 54.84 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 104.66 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.8 p -59.57 171.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 7.4 t 53.9 37.24 26.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.518 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.1 m -80.07 145.25 32.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.854 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 2.1 m -154.49 115.44 4.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -129.8 23.35 4.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.3 p -78.08 97.0 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.5 m -105.35 -55.03 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 97.6 88.39 1.87 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.74 60.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -84.35 160.7 56.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.523 0.677 . . . . 0.0 110.924 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.27 104.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 66.8 t -103.35 132.15 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.61 127.95 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.2 p -95.98 25.07 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -120.77 -46.32 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.99 -29.22 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 95.61 81.18 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -153.68 127.93 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.46 148.15 25.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.28 100.24 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.26 -34.53 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -82.58 155.47 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -103.78 36.43 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.1 t -132.51 -45.88 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -68.03 -28.11 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -70.83 -51.04 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.48 -32.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.4 m -87.21 -25.14 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -70.95 -16.86 62.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -80.48 -22.97 40.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -62.46 -44.96 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -57.75 -22.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -92.33 -48.24 6.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 75.1 p -72.4 99.01 2.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -165.67 -63.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.485 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.25 -64.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 87.9 p -107.06 27.58 8.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.06 -71.52 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 91.93 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.8 t -152.91 157.31 40.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 6.6 p -92.99 -46.68 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.463 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 57.3 p -113.99 102.11 9.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.6 t -161.21 176.71 10.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.871 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 72.91 128.59 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.5 t -152.95 118.03 5.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.1 t -85.54 77.85 9.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.85 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -94.95 76.5 0.9 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.13 103.8 12.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -129.79 160.64 63.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.538 0.685 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -166.29 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.376 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.21 104.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 93.3 t -102.88 116.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.98 130.78 30.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 81.3 p -95.13 25.0 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -122.96 -35.85 2.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.8 p -119.52 -40.44 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.48 42.52 1.59 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.68 136.25 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.328 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -93.6 146.31 23.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -135.38 101.74 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.79 -35.87 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 26.76 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.5 t -125.03 -46.23 1.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -62.27 -35.88 80.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -61.65 -55.11 34.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.98 -51.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -66.72 -25.11 66.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -77.72 -16.64 58.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.48 -23.33 40.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -62.19 -45.18 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -57.63 -23.0 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -92.45 -31.83 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 39.3 p -100.8 25.9 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -107.07 32.14 7.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -117.7 169.21 9.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 t -173.01 127.53 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -178.24 -71.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.469 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.51 18.52 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 3.6 m -74.9 102.21 4.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 9.2 p -120.2 140.14 51.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.437 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 48.6 m -101.75 144.5 30.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 47.4 t -57.68 -53.79 54.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 52.64 79.96 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.463 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.1 m -134.37 147.67 50.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.6 m -126.27 142.25 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 141.57 135.82 3.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -123.76 131.44 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.923 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -144.79 160.64 46.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.571 0.701 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 -166.32 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.24 105.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 95.1 t -107.25 114.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 9.0 t -52.03 130.7 30.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 74.0 p -95.23 25.16 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -122.75 -35.8 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.45 -40.79 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.99 43.78 1.36 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.11 134.38 55.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -95.31 147.88 23.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -135.64 99.72 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.03 -30.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -81.07 174.43 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -120.93 25.97 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.2 m -125.53 -45.19 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -64.24 -27.86 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -70.43 -56.53 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.71 -32.45 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -88.12 -25.03 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.48 -16.72 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -80.34 -23.44 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -62.09 -45.23 94.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.2 tt -57.9 -22.67 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.48 -65.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 42.1 p -51.92 -49.59 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -100.18 56.47 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -103.92 140.97 36.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.5 p -83.67 76.67 9.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -147.35 68.1 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 94.87 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.639 2.226 . . . . 0.0 112.336 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.7 t -55.56 161.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.5 t -53.69 -30.24 42.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.503 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 88.1 p -173.31 147.9 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 47.7 m -145.16 145.17 31.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 80.28 110.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.447 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 16.1 p -93.74 153.26 18.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 110.798 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 8.0 t -93.92 -67.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 171.53 -165.46 38.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.452 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -122.93 89.89 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -73.95 160.65 81.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.37 107.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 83.2 t -108.26 116.08 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.121 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 25.8 t -52.1 127.02 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 22.5 p -95.24 25.96 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -121.88 -48.64 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.27 -26.44 8.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.29 81.98 1.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -151.21 124.75 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.96 141.83 28.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -134.58 103.24 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.5 -37.15 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -78.24 162.94 26.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -110.18 31.65 5.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.2 p -126.49 -50.06 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.92 -27.66 68.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -70.46 -54.74 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.72 -33.37 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 90.9 m -86.7 -25.1 24.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -71.95 -17.22 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.21 -22.43 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -63.17 -44.75 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 11.9 tt -58.13 -22.23 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -95.48 -62.37 1.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 64.2 p -52.7 -44.41 66.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -63.32 -84.29 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.98 132.13 38.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.4 m 54.49 47.21 23.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -155.29 169.04 33.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 116.84 4.74 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.9 p -72.41 123.74 23.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 16.3 p -114.17 55.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.83 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.488 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.9 m -149.1 115.38 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.887 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.4 m -95.54 161.35 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -130.02 -152.26 7.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 16.9 p -138.87 168.54 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 4.4 t -89.36 96.88 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -179.56 89.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -53.12 114.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -113.16 159.19 35.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -166.31 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -50.46 109.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 99.5 t -105.83 117.93 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.14 137.16 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.8 p -95.41 26.81 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.62 -40.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.5 -28.99 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.09 30.05 9.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -95.6 138.6 33.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -92.1 141.7 28.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -127.77 90.53 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 76.9 mt -51.78 -29.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -85.89 164.38 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -111.36 28.24 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 m -128.68 -39.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -71.56 -28.14 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.1 -44.47 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.8 mt -65.42 -27.62 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -90.53 -25.07 20.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.54 -23.93 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -70.37 -24.86 63.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -64.9 -59.27 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.6 tt -53.01 -28.42 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -77.0 -40.02 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 30.8 p -79.22 91.49 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -93.95 -179.38 38.78 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.02 97.56 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 10.5 p -127.67 50.25 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -153.17 68.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.466 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 135.21 29.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.348 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 51.0 m -84.24 62.93 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.3 m -99.87 -55.19 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.461 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -85.31 97.11 9.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.84 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 33.8 t -94.14 -31.3 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 104.73 -135.41 12.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 40.0 m -125.88 159.14 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.7 m -141.07 -177.48 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 81.92 76.94 1.06 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.444 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -109.34 70.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.72 160.71 67.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.667 2.244 . . . . 0.0 112.41 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.26 104.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.36 124.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 11.2 t -60.52 127.49 31.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 19.0 p -96.18 29.48 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.77 -47.11 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.74 -27.2 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.16 82.7 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -156.18 128.07 7.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.11 146.61 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.56 100.71 4.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.27 -33.03 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -83.24 152.76 25.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -99.28 27.11 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.6 t -124.73 -49.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.28 -40.22 85.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -57.36 -54.44 46.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.83 -55.2 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -61.22 -25.56 67.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.169 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -80.43 -17.61 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -79.71 -21.72 44.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -63.97 -44.92 91.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.1 tt -58.73 -21.54 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -95.69 -27.01 15.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 74.0 p -103.22 70.19 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 170.13 -100.92 0.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -100.64 155.85 17.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.369 . . . . 0.0 110.881 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.9 t 58.38 32.72 22.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.96 32.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 119.56 6.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.314 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.4 p -149.42 172.56 14.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.1 m 52.26 50.58 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.862 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 CA-C-O 119.16 -0.8 . . . . 0.0 112.497 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 4.3 p -129.88 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 103.79 146.21 15.96 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.5 p -87.2 85.28 7.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 3.5 t -134.58 112.93 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -135.11 149.43 19.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -101.49 87.48 3.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -124.69 160.63 52.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.52 0.676 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.661 2.241 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.25 109.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 63.7 t -105.64 124.32 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.197 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.4 t -60.15 127.45 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 43.9 p -95.33 25.2 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.19 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -124.09 -46.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.2 p -113.24 -27.25 8.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.846 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 90.41 78.86 1.35 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -151.63 132.49 14.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.31 148.36 26.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.02 95.87 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.84 -27.17 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -83.84 155.95 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.62 32.72 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.7 p -139.89 -45.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.16 -28.33 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.57 -55.21 5.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.18 -32.5 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 91.9 m -84.66 -26.36 27.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -74.36 -17.96 60.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.82 -22.88 52.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 13.0 tt -60.43 -19.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -93.37 -61.55 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 67.0 p -59.55 97.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -145.14 167.63 27.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -124.89 81.81 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 2.3 m -122.74 103.57 8.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 111.44 179.26 20.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 166.27 28.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.647 2.231 . . . . 0.0 112.366 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.7 p -64.55 132.02 48.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 49.1 m -119.89 160.79 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.475 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.1 p -136.48 -176.25 4.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.851 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 60.0 p -149.04 148.39 29.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 151.54 68.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 32.1 t -97.98 97.13 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.0 t -105.4 151.66 23.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 133.35 118.66 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -108.59 116.02 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -91.45 160.66 36.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.544 0.687 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -166.26 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -50.36 110.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' VAL . . . . . . . . . . . . . 70.4 t -104.84 131.82 53.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.5 128.48 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 51.3 p -95.99 25.11 4.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -126.97 -44.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.13 -26.88 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 88.92 84.41 1.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -154.68 123.8 6.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -77.57 144.79 37.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -135.24 96.88 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.57 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -84.32 159.29 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.09 24.79 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.0 p -134.26 -44.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -60.46 -26.72 66.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -78.26 -56.34 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.6 mt -54.34 -30.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 93.6 m -85.13 -25.56 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -82.33 -18.23 42.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -78.52 -23.04 46.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -59.63 -45.49 91.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.0 tt -57.29 -23.3 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -95.64 25.43 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 48.6 p -148.93 -173.16 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 68.14 91.52 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -138.24 157.95 45.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.891 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 31.1 m -82.44 63.16 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.76 -71.63 0.79 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 174.15 9.89 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.688 2.258 . . . . 0.0 112.378 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 41.2 t -91.37 -38.96 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.0 p 55.84 27.45 10.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.487 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.622 0.725 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.69 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.81 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.308 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.23 105.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 411' ' ' PRO . 80.5 t -106.78 115.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 40.3 t -53.12 127.2 23.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 70.6 p -96.54 31.46 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -125.86 -42.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.35 -33.11 3.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.07 86.19 1.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -158.06 124.92 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.07 143.92 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.053 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -133.18 97.14 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.85 -27.78 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -90.66 162.4 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -107.64 40.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 57.4 p -133.55 -54.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -72.37 -53.61 11.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.65 -37.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.5 m -74.95 -27.65 60.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.68 -25.35 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -68.35 -25.56 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -63.87 -60.46 3.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.8 tt -53.18 -28.34 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.613 0.721 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.73 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.22 107.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 411' ' ' PRO . 81.4 t -107.9 129.87 61.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 53.1 t -70.48 130.1 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 69.9 p -95.96 37.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -128.5 -41.08 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 16.8 p -123.1 -36.59 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.76 80.65 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -151.87 128.28 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -88.84 143.49 26.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -130.99 99.21 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.61 -37.73 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -88.13 152.25 22.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -96.03 42.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.9 p -131.77 -44.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -67.98 -26.59 66.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.86 -51.43 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.73 -32.55 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -82.79 -28.29 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -67.84 -24.49 65.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -69.38 -24.5 63.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -59.34 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 tt -53.11 -28.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.72 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.71 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.274 . . . . 0.0 112.345 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.19 106.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 411' ' ' PRO . 92.2 t -109.86 122.41 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.5 t -52.83 127.77 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 28.8 p -95.45 27.82 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -130.2 -45.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 22.0 p -116.69 -26.75 6.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.14 79.36 1.43 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.81 116.17 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.324 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.483 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -85.18 140.66 30.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.42 100.99 4.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -53.24 -29.68 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.45 168.96 13.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -111.02 26.88 10.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 96.1 p -125.06 -50.08 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -59.29 -36.11 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.42 -57.29 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.82 -51.62 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -65.66 -25.69 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.67 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.4 t60 -75.74 -19.26 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.44 -23.05 43.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -59.01 -45.94 89.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.9 tt -51.61 -30.02 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.641 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.29 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.25 106.61 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 411' ' ' PRO . 91.7 t -103.75 119.78 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.7 t -52.07 124.66 13.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 73.3 p -95.52 31.78 1.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.43 -43.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.67 -28.92 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 94.11 84.4 1.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -156.44 124.71 5.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.92 141.54 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.17 101.19 5.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.14 -35.49 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -80.83 157.18 25.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -102.09 26.03 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.9 t -125.69 -49.6 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.28 -34.93 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -63.08 -59.54 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.75 -48.42 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 30.1 m -65.74 -31.57 72.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -75.07 -18.33 60.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -79.53 -23.3 42.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 32.6 mtp85 -58.96 -46.18 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -53.6 -27.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.82 -166.27 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.286 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.3 106.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 411' ' ' PRO . 61.2 t -102.79 131.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.48 126.59 28.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 31.8 p -95.52 28.07 3.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -129.72 -45.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.23 -28.17 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.0 84.83 1.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -157.36 127.8 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.28 28.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.97 100.19 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.95 -31.0 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 40.7 mtm-85 -82.54 154.91 24.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -103.24 26.08 8.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 6.9 t -129.44 -40.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.42 -29.83 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.66 -52.83 22.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.63 -35.86 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.3 m -83.3 -25.54 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -69.36 -18.21 63.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.06 -22.95 44.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -59.6 -45.88 90.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -55.88 -25.02 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.866 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.2 mttp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.5 Cg_endo -69.71 -166.27 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.393 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.25 106.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 411' ' ' PRO . 87.8 t -103.7 133.61 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.95 126.97 31.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 18.1 p -96.59 29.99 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.01 -43.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.87 -31.36 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 98.64 85.3 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.471 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -157.92 128.55 6.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.3 26.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.84 103.17 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.47 -31.06 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -80.31 163.86 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -109.49 29.2 7.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 48.0 t -123.93 -61.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -52.56 -42.43 64.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.4 -49.98 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.9 mt -67.41 -32.39 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.533 HG23 ' NH1' ' A' ' 432' ' ' ARG . 2.6 m -94.34 20.43 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.678 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -116.35 -18.63 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.6 -23.48 42.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ARG . . . . . 0.533 ' NH1' HG23 ' A' ' 429' ' ' THR . 1.4 mpt_? -58.6 -46.3 87.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -52.24 -29.24 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.58 0.705 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.79 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.22 111.61 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 411' ' ' PRO . 79.0 t -110.22 118.96 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 34.3 t -55.37 130.76 43.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 23.3 p -99.81 29.06 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -127.2 -43.8 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 30.9 p -117.03 -28.34 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.76 87.09 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -160.11 127.38 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.22 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.54 101.15 4.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.28 -32.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -79.21 152.07 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -102.01 26.44 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 t -125.38 -46.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.69 -27.95 68.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -70.24 -51.23 32.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.93 -31.36 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.9 m -88.38 -25.12 22.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.5 t60 -71.99 -16.55 62.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.13 -23.6 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -45.04 95.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.5 tt -55.79 -25.11 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.535 0.683 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.639 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.78 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.23 106.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -102.97 123.36 56.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 17.8 t -58.25 125.51 23.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.3 p -95.91 29.79 2.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -126.31 -46.37 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.8 p -116.88 -28.56 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.32 86.92 1.78 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -160.11 125.67 4.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.56 145.69 27.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.17 102.18 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.7 mt -58.72 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 27.7 mtm-85 -86.71 150.81 23.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -96.87 26.37 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.1 p -125.81 -48.46 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.06 -33.23 72.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.84 -57.46 8.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.18 -48.78 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.4 m -67.37 -25.44 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.4 t60 -79.64 -16.73 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.99 -23.38 38.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -61.76 -44.98 95.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.08 -24.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.862 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.76 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.388 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.2 105.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 411' ' ' PRO . 86.5 t -103.16 118.66 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.5 t -57.73 125.73 24.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 60.1 p -95.61 28.51 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -123.15 -44.96 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.8 -30.03 5.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 97.28 82.47 1.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -157.45 129.77 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.335 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -91.11 141.54 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.075 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -130.17 102.9 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.81 -27.13 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -84.77 152.37 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -101.9 26.24 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 72.4 p -125.62 -46.68 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.83 -26.3 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -71.69 -48.48 47.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.26 -29.66 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.1 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -90.27 -25.17 20.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.659 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -69.67 -16.7 63.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -81.05 -23.22 38.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -61.97 -44.85 95.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.06 -24.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 26.2 mttp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.8 -166.29 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.315 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.25 104.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -100.66 120.92 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.87 126.68 28.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 71.6 p -95.69 25.35 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -121.98 -40.65 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 24.4 p -118.62 -31.78 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.14 79.56 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -155.63 130.77 9.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.4 146.96 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.03 100.21 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.35 -25.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 144.38 30.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -96.62 26.01 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 4.9 m -131.69 -40.74 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.01 -33.13 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.3 -56.66 10.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.7 -45.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -71.49 -33.92 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -66.8 -16.55 64.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.06 -23.51 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -61.59 -45.15 95.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -56.06 -24.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.572 0.701 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.673 2.249 . . . . 0.0 112.317 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.16 104.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.6 t -101.06 120.78 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.38 126.59 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 17.7 p -96.82 31.69 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -132.3 -44.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.2 p -114.16 -28.85 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.44 82.92 1.49 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -156.91 130.01 7.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.68 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -137.02 100.64 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.32 -25.59 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -81.85 148.59 28.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -99.88 25.87 6.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 75.1 p -131.6 -41.36 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -67.66 -34.17 76.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -66.18 -55.52 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -52.48 -42.46 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.0 m -73.84 -33.92 64.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.661 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -69.87 -17.1 63.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.75 -22.62 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -62.66 -44.73 95.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.41 -24.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 29.1 mttm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.86 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.662 2.242 . . . . 0.0 112.332 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.25 105.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.3 t -99.84 141.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.3 t -78.08 128.09 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -95.59 27.87 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -127.96 -42.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.5 p -117.62 -30.3 5.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.59 80.94 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.529 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -154.64 130.17 9.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.39 26.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.86 98.08 3.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.68 -25.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -84.07 156.1 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 31.66 4.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 87.3 p -138.5 -44.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.49 -27.17 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -74.19 -57.57 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.5 mt -51.93 -41.0 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.5 m -74.94 -27.5 60.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -74.76 -16.77 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.61 -23.16 39.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -62.14 -45.09 94.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.11 -23.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.523 0.677 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.82 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.27 104.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.8 t -103.35 132.15 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.61 127.95 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.2 p -95.98 25.07 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -120.77 -46.32 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.99 -29.22 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 95.61 81.18 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -153.68 127.93 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.46 148.15 25.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.28 100.24 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.26 -34.53 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -82.58 155.47 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -103.78 36.43 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.1 t -132.51 -45.88 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -68.03 -28.11 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -70.83 -51.04 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.48 -32.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.4 m -87.21 -25.14 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -70.95 -16.86 62.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -80.48 -22.97 40.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -62.46 -44.96 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -57.75 -22.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.849 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 37.5 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.538 0.685 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.3 Cg_endo -69.77 -166.29 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.376 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.21 104.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 411' ' ' PRO . 93.3 t -102.88 116.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.98 130.78 30.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 81.3 p -95.13 25.0 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -122.96 -35.85 2.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.8 p -119.52 -40.44 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.48 42.52 1.59 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.68 136.25 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.328 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -93.6 146.31 23.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -135.38 101.74 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.79 -35.87 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 26.76 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.5 t -125.03 -46.23 1.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -62.27 -35.88 80.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -61.65 -55.11 34.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.98 -51.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -66.72 -25.11 66.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -77.72 -16.64 58.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.48 -23.33 40.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -62.19 -45.18 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.63 -23.0 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.915 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.571 0.701 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.691 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.73 -166.32 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.24 105.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 411' ' ' PRO . 95.1 t -107.25 114.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 9.0 t -52.03 130.7 30.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 74.0 p -95.23 25.16 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -122.75 -35.8 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.45 -40.79 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.99 43.78 1.36 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.11 134.38 55.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -95.31 147.88 23.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -135.64 99.72 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.03 -30.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -81.07 174.43 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -120.93 25.97 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.2 m -125.53 -45.19 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -64.24 -27.86 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -70.43 -56.53 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.71 -32.45 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -88.12 -25.03 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -72.48 -16.72 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -80.34 -23.44 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -62.09 -45.23 94.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.9 -22.67 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.841 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.592 0.711 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.6 Cg_endo -69.77 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.37 107.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 411' ' ' PRO . 83.2 t -108.26 116.08 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.121 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 25.8 t -52.1 127.02 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 22.5 p -95.24 25.96 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -121.88 -48.64 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.27 -26.44 8.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.29 81.98 1.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -151.21 124.75 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.96 141.83 28.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -134.58 103.24 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.5 -37.15 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -78.24 162.94 26.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -110.18 31.65 5.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.2 p -126.49 -50.06 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.92 -27.66 68.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -70.46 -54.74 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.72 -33.37 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 90.9 m -86.7 -25.1 24.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -71.95 -17.22 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.21 -22.43 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -63.17 -44.75 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 430' ' ' HIS . 11.9 tt -58.13 -22.23 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.867 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.566 0.698 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.617 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.7 Cg_endo -69.78 -166.31 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -50.46 109.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 411' ' ' PRO . 99.5 t -105.83 117.93 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.14 137.16 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.8 p -95.41 26.81 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.62 -40.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.5 -28.99 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.09 30.05 9.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -95.6 138.6 33.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -92.1 141.7 28.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -127.77 90.53 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 76.9 mt -51.78 -29.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -85.89 164.38 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -111.36 28.24 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 m -128.68 -39.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -71.56 -28.14 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.1 -44.47 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.8 mt -65.42 -27.62 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -90.53 -25.07 20.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.54 -23.93 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -70.37 -24.86 63.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -64.9 -59.27 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.6 tt -53.01 -28.42 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.587 0.708 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.75 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.667 2.244 . . . . 0.0 112.41 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.26 104.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 411' ' ' PRO . 76.5 t -102.36 124.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 11.2 t -60.52 127.49 31.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 19.0 p -96.18 29.48 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.77 -47.11 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.74 -27.2 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.16 82.7 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -156.18 128.07 7.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.11 146.61 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.56 100.71 4.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.27 -33.03 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -83.24 152.76 25.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -99.28 27.11 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.6 t -124.73 -49.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.28 -40.22 85.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -57.36 -54.44 46.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.83 -55.2 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -61.22 -25.56 67.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.169 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.65 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.5 t60 -80.43 -17.61 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -79.71 -21.72 44.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -63.97 -44.92 91.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -58.73 -21.54 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.52 0.676 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.77 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.661 2.241 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.25 109.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 63.7 t -105.64 124.32 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.4 t -60.15 127.45 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 43.9 p -95.33 25.2 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.19 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -124.09 -46.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.2 p -113.24 -27.25 8.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.846 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 90.41 78.86 1.35 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -151.63 132.49 14.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.31 148.36 26.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.02 95.87 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.84 -27.17 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -83.84 155.95 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.62 32.72 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.7 p -139.89 -45.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -61.16 -28.33 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.57 -55.21 5.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.18 -32.5 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' THR . . . . . 0.406 HG23 HH11 ' A' ' 432' ' ' ARG . 91.9 m -84.66 -26.36 27.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.9 t60 -74.36 -17.96 60.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.82 -22.88 52.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ARG . . . . . 0.406 HH11 HG23 ' A' ' 429' ' ' THR . 61.9 mtt180 -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.0 tt -60.43 -19.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.544 0.687 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 411' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.79 -166.26 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -50.36 110.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 411' ' ' PRO . 70.4 t -104.84 131.82 53.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.5 128.48 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 51.3 p -95.99 25.11 4.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -126.97 -44.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.13 -26.88 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 88.92 84.41 1.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -154.68 123.8 6.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -77.57 144.79 37.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -135.24 96.88 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.57 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -84.32 159.29 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.09 24.79 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.0 p -134.26 -44.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -60.46 -26.72 66.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -78.26 -56.34 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.6 mt -54.34 -30.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 93.6 m -85.13 -25.56 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' HIS . . . . . 0.692 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.3 t60 -82.33 -18.23 42.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -78.52 -23.04 46.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -59.63 -45.49 91.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -57.29 -23.3 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 27.7 m -132.41 58.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.357 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.5 m -102.51 33.02 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.09 -81.71 1.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 m 59.43 46.03 12.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.6 m -143.86 157.34 44.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.85 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.63 53.77 4.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.65 118.5 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.957 0.408 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -94.39 160.71 31.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.69 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.81 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.308 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.23 105.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 411' ' ' PRO . 80.5 t -106.78 115.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 40.3 t -53.12 127.2 23.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 70.6 p -96.54 31.46 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -125.86 -42.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.35 -33.11 3.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.07 86.19 1.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -158.06 124.92 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.07 143.92 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.053 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -133.18 97.14 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.85 -27.78 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -90.66 162.4 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -107.64 40.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 57.4 p -133.55 -54.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -72.37 -53.61 11.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.65 -37.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.5 m -74.95 -27.65 60.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.68 -25.35 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -68.35 -25.56 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -63.87 -60.46 3.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.8 tt -53.18 -28.34 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -79.17 -64.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 78.0 p -55.87 103.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -64.04 -35.53 92.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.509 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -123.81 134.71 53.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 5.3 t -173.01 120.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.11 27.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -40.39 5.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 53.7 p -60.36 -36.99 79.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.3 p -96.44 147.49 23.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.501 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.7 t -112.56 86.22 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.905 0.383 . . . . 0.0 110.864 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 16.9 t -98.69 -52.46 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.883 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.62 174.15 54.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.2 p -151.13 108.78 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 110.817 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 -56.91 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -102.78 165.1 16.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -169.89 150.92 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -87.2 160.65 48.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.73 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.22 107.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 411' ' ' PRO . 81.4 t -107.9 129.87 61.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 53.1 t -70.48 130.1 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 69.9 p -95.96 37.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -128.5 -41.08 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 16.8 p -123.1 -36.59 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.76 80.65 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -151.87 128.28 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -88.84 143.49 26.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -130.99 99.21 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.61 -37.73 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -88.13 152.25 22.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -96.03 42.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.9 p -131.77 -44.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -67.98 -26.59 66.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.86 -51.43 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.73 -32.55 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -82.79 -28.29 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -67.84 -24.49 65.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -69.38 -24.5 63.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -59.34 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 tt -53.11 -28.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -81.09 -42.2 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 74.2 p -85.42 84.1 7.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -104.87 75.34 0.24 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -134.07 41.07 3.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.902 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 18.9 m -115.33 52.55 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -84.54 170.21 46.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 146.03 59.5 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.382 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 t 52.55 50.7 17.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 p -128.12 162.91 25.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.488 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 8.1 t 62.36 31.61 17.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.84 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 72.4 m -114.58 -66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.59 66.71 1.01 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.5 t -68.98 134.13 49.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.832 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 3.2 m -61.8 167.44 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -138.66 144.39 15.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.521 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.14 27.9 8.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.896 0.379 . . . . 0.0 110.864 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -98.82 160.64 27.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.505 0.669 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.72 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.71 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.274 . . . . 0.0 112.345 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.19 106.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 411' ' ' PRO . 92.2 t -109.86 122.41 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.5 t -52.83 127.77 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 28.8 p -95.45 27.82 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -130.2 -45.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 22.0 p -116.69 -26.75 6.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.14 79.36 1.43 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.81 116.17 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.324 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.483 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -85.18 140.66 30.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.42 100.99 4.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -53.24 -29.68 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.45 168.96 13.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -111.02 26.88 10.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 96.1 p -125.06 -50.08 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -59.29 -36.11 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.42 -57.29 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.82 -51.62 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -65.66 -25.69 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.67 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.4 t60 -75.74 -19.26 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.44 -23.05 43.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -59.01 -45.94 89.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.9 tt -51.61 -30.02 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -89.1 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 39.9 p -52.12 -62.97 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 137.93 -73.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.425 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -169.4 110.14 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.8 m -101.48 69.87 1.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.818 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.45 175.76 7.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 105.09 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.9 t -69.35 112.33 5.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 14.5 t -110.03 74.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-O 119.112 -0.826 . . . . 0.0 112.506 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.4 m -117.37 93.18 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.809 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.1 m -164.44 162.59 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 145.88 59.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 66.4 m -140.78 -179.59 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 59.8 p -157.07 154.73 29.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -170.33 81.69 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.15 176.68 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.404 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -132.54 160.73 67.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.641 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.29 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.25 106.61 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 411' ' ' PRO . 91.7 t -103.75 119.78 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.7 t -52.07 124.66 13.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 73.3 p -95.52 31.78 1.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.43 -43.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.67 -28.92 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 94.11 84.4 1.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -156.44 124.71 5.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.92 141.54 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.17 101.19 5.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.14 -35.49 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -80.83 157.18 25.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -102.09 26.03 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.9 t -125.69 -49.6 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.28 -34.93 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -63.08 -59.54 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.75 -48.42 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 30.1 m -65.74 -31.57 72.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -75.07 -18.33 60.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -79.53 -23.3 42.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 32.6 mtp85 -58.96 -46.18 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -53.6 -27.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -86.24 -41.05 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 73.6 p -66.36 -26.97 67.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -98.64 -86.5 1.87 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.26 170.6 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.363 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 58.8 m -95.66 -67.12 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -136.85 173.71 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.496 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -26.99 26.74 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 13.3 p -130.1 158.9 38.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 p -158.4 125.17 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.502 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 20.2 m -106.94 49.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.8 t -153.22 155.37 36.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -170.08 49.19 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 94.0 p -143.01 127.35 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 20.0 p -88.49 -27.02 21.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 111.76 -156.43 15.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -113.3 132.41 55.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 0.0 110.912 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -154.33 160.72 30.63 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.82 -166.27 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.286 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.3 106.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 411' ' ' PRO . 61.2 t -102.79 131.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.48 126.59 28.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 31.8 p -95.52 28.07 3.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -129.72 -45.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.23 -28.17 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.0 84.83 1.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -157.36 127.8 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.28 28.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.97 100.19 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.95 -31.0 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 40.7 mtm-85 -82.54 154.91 24.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -103.24 26.08 8.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 6.9 t -129.44 -40.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.42 -29.83 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.66 -52.83 22.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.63 -35.86 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.3 m -83.3 -25.54 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -69.36 -18.21 63.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.06 -22.95 44.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -59.6 -45.88 90.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -55.88 -25.02 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -87.47 -30.78 20.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 71.5 p -81.64 78.27 8.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.16 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -96.68 67.05 0.95 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.441 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -113.98 55.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.877 0.37 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 t -121.81 -49.48 2.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -152.23 -72.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 115.45 4.1 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.696 2.264 . . . . 0.0 112.348 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.3 t -146.4 151.13 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 8.5 t -100.45 47.63 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 119.179 -0.789 . . . . 0.0 112.521 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 p -151.72 152.17 32.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.858 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 2.0 t -93.12 127.02 38.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -174.08 -59.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 m -116.44 133.52 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.883 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 1.4 t -115.32 -29.55 6.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 110.56 105.53 2.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -110.67 35.94 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -99.24 160.65 27.04 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.534 0.683 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.5 Cg_endo -69.71 -166.27 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.393 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.25 106.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 411' ' ' PRO . 87.8 t -103.7 133.61 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.95 126.97 31.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 18.1 p -96.59 29.99 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.01 -43.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.87 -31.36 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 98.64 85.3 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.471 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -157.92 128.55 6.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.3 26.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.84 103.17 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.47 -31.06 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -80.31 163.86 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -109.49 29.2 7.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 48.0 t -123.93 -61.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -52.56 -42.43 64.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.4 -49.98 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.9 mt -67.41 -32.39 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.533 HG23 ' NH1' ' A' ' 432' ' ' ARG . 2.6 m -94.34 20.43 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.678 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -116.35 -18.63 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.6 -23.48 42.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ARG . . . . . 0.533 ' NH1' HG23 ' A' ' 429' ' ' THR . 1.4 mpt_? -58.6 -46.3 87.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -52.24 -29.24 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -87.69 -47.51 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 66.5 p -74.28 74.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 173.04 74.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.33 175.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.34 59.52 5.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 104.25 69.14 0.77 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.71 15.93 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.733 2.288 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.9 m -65.78 99.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.5 t -113.15 143.11 44.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.49 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 t -58.04 140.62 52.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -95.65 90.25 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -83.2 -139.82 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 20.0 m -150.88 135.86 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.845 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 29.9 t -97.82 -51.81 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.68 145.25 5.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 101.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -117.13 160.66 36.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.58 0.705 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.79 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.22 111.61 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 411' ' ' PRO . 79.0 t -110.22 118.96 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 34.3 t -55.37 130.76 43.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 23.3 p -99.81 29.06 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -127.2 -43.8 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 30.9 p -117.03 -28.34 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.76 87.09 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -160.11 127.38 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.22 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.54 101.15 4.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.28 -32.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -79.21 152.07 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -102.01 26.44 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 t -125.38 -46.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.69 -27.95 68.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -70.24 -51.23 32.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.93 -31.36 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.9 m -88.38 -25.12 22.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.5 t60 -71.99 -16.55 62.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.13 -23.6 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -45.04 95.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.5 tt -55.79 -25.11 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -95.51 -28.84 14.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 67.2 p -104.52 40.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -98.8 -50.89 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.51 157.47 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 73.6 m -93.79 44.12 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -165.38 69.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.41 11.02 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.9 t -117.92 119.47 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.6 p -78.44 -35.38 46.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.04 109.8 18.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.9 p -159.26 168.53 26.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 139.49 -159.03 25.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 73.8 p -151.12 115.91 5.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.837 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 60.1 p -96.41 33.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -176.07 -137.31 2.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -162.66 139.87 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -134.35 160.66 67.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.535 0.683 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.639 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.78 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.23 106.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -102.97 123.36 56.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 17.8 t -58.25 125.51 23.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.3 p -95.91 29.79 2.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -126.31 -46.37 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.8 p -116.88 -28.56 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.32 86.92 1.78 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -160.11 125.67 4.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.56 145.69 27.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.17 102.18 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.7 mt -58.72 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 27.7 mtm-85 -86.71 150.81 23.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -96.87 26.37 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.1 p -125.81 -48.46 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.06 -33.23 72.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.84 -57.46 8.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.18 -48.78 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.4 m -67.37 -25.44 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.4 t60 -79.64 -16.73 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.99 -23.38 38.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -61.76 -44.98 95.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.08 -24.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -94.36 -27.01 16.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 76.8 p -104.07 30.55 5.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -92.64 153.02 21.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.45 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -119.31 143.73 47.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.915 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.6 m 58.71 28.48 17.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -139.65 -74.61 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -17.21 37.69 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.622 2.215 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 110.66 20.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.81 -62.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.5 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.2 m -95.06 -51.92 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.4 m -83.13 178.42 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 101.52 160.95 27.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 61.7 m -97.82 82.92 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.856 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 18.6 m -113.78 -178.36 3.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 105.2 -94.72 1.03 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.534 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.95 45.37 18.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -134.79 160.7 67.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.76 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.388 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.2 105.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 411' ' ' PRO . 86.5 t -103.16 118.66 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.5 t -57.73 125.73 24.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 60.1 p -95.61 28.51 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -123.15 -44.96 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.8 -30.03 5.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 97.28 82.47 1.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -157.45 129.77 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.335 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -91.11 141.54 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.075 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -130.17 102.9 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.81 -27.13 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -84.77 152.37 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -101.9 26.24 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 72.4 p -125.62 -46.68 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.83 -26.3 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -71.69 -48.48 47.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.26 -29.66 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.1 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -90.27 -25.17 20.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.659 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -69.67 -16.7 63.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -81.05 -23.22 38.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -61.97 -44.85 95.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.06 -24.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.35 -35.42 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 46.7 p -91.8 44.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.112 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -130.61 -162.05 10.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -129.81 48.76 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.863 0.363 . . . . 0.0 110.853 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.7 p -88.78 59.9 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -176.04 -171.36 39.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -48.18 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.7 m -60.68 132.61 54.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.2 p -121.56 -58.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.488 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.1 m -67.94 112.81 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.844 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.3 p -159.34 165.2 33.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 105.93 58.08 0.64 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 m -65.39 130.84 44.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 29.7 t -144.31 109.25 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -167.09 105.12 0.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -130.17 156.69 44.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -106.87 160.68 25.44 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.566 0.698 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.8 -166.29 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.315 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.25 104.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -100.66 120.92 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.87 126.68 28.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 71.6 p -95.69 25.35 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -121.98 -40.65 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 24.4 p -118.62 -31.78 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.14 79.56 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -155.63 130.77 9.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.4 146.96 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.03 100.21 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.35 -25.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 144.38 30.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -96.62 26.01 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 4.9 m -131.69 -40.74 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.01 -33.13 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.3 -56.66 10.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.7 -45.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -71.49 -33.92 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -66.8 -16.55 64.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.06 -23.51 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -61.59 -45.15 95.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -56.06 -24.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -89.46 -28.6 19.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 75.2 p -95.6 69.14 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 177.33 -118.44 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.481 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.08 -53.54 5.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.0 t 62.97 49.55 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -153.24 69.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -33.88 15.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 7.7 p -88.8 -33.15 17.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 m 61.01 53.11 3.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.105 -0.831 . . . . 0.0 112.476 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 91.6 p -109.1 125.14 51.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.881 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 m -114.71 134.85 54.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 152.46 82.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.0 m -122.89 154.07 38.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 0.0 110.852 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.5 p -131.12 78.62 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -108.77 101.0 1.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.26 69.29 0.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -115.7 160.7 33.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.673 2.249 . . . . 0.0 112.317 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.16 104.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.6 t -101.06 120.78 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.38 126.59 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 17.7 p -96.82 31.69 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -132.3 -44.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.2 p -114.16 -28.85 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.44 82.92 1.49 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -156.91 130.01 7.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.68 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -137.02 100.64 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.32 -25.59 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -81.85 148.59 28.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -99.88 25.87 6.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 75.1 p -131.6 -41.36 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -67.66 -34.17 76.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -66.18 -55.52 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -52.48 -42.46 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.0 m -73.84 -33.92 64.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.661 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -69.87 -17.1 63.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.75 -22.62 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -62.66 -44.73 95.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.41 -24.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -92.33 -42.32 9.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 79.0 p -88.92 103.1 15.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 145.5 83.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.448 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.37 68.17 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 9.1 t -173.46 118.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -166.61 -173.52 35.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.497 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 -22.69 32.19 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.258 . . . . 0.0 112.368 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.3 p -54.44 131.73 42.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.9 p -131.35 79.51 1.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.481 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -95.03 -39.8 9.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.357 . . . . 0.0 110.882 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 83.7 p -62.14 -35.07 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -94.48 23.78 30.61 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.8 t -114.65 92.44 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.8 p -94.74 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 177.9 -165.88 35.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.539 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.45 57.34 3.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -106.09 160.73 25.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.86 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.662 2.242 . . . . 0.0 112.332 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.25 105.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.3 t -99.84 141.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.3 t -78.08 128.09 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -95.59 27.87 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -127.96 -42.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.5 p -117.62 -30.3 5.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.59 80.94 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.529 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -154.64 130.17 9.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.39 26.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.86 98.08 3.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.68 -25.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -84.07 156.1 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 31.66 4.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 87.3 p -138.5 -44.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.49 -27.17 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -74.19 -57.57 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.5 mt -51.93 -41.0 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.5 m -74.94 -27.5 60.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -74.76 -16.77 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.61 -23.16 39.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -62.14 -45.09 94.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.11 -23.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -89.02 -37.62 15.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 66.8 p -81.36 85.92 6.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -109.08 -170.62 20.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -121.13 27.11 8.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 30.6 t -54.21 -47.66 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -76.33 171.05 54.84 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 104.66 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.8 p -59.57 171.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 7.4 t 53.9 37.24 26.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.518 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.1 m -80.07 145.25 32.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.854 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 2.1 m -154.49 115.44 4.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -129.8 23.35 4.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.3 p -78.08 97.0 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.5 m -105.35 -55.03 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 97.6 88.39 1.87 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.74 60.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -84.35 160.7 56.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.523 0.677 . . . . 0.0 110.924 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.82 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.27 104.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.8 t -103.35 132.15 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.61 127.95 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.2 p -95.98 25.07 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -120.77 -46.32 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.99 -29.22 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 95.61 81.18 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -153.68 127.93 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.46 148.15 25.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.28 100.24 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.26 -34.53 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -82.58 155.47 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -103.78 36.43 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.1 t -132.51 -45.88 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -68.03 -28.11 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -70.83 -51.04 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.48 -32.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.4 m -87.21 -25.14 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -70.95 -16.86 62.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -80.48 -22.97 40.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -62.46 -44.96 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -57.75 -22.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -92.33 -48.24 6.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 75.1 p -72.4 99.01 2.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -165.67 -63.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.485 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.25 -64.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 87.9 p -107.06 27.58 8.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.06 -71.52 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 91.93 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.8 t -152.91 157.31 40.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 6.6 p -92.99 -46.68 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.463 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 57.3 p -113.99 102.11 9.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.6 t -161.21 176.71 10.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.871 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 72.91 128.59 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.5 t -152.95 118.03 5.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.1 t -85.54 77.85 9.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.85 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -94.95 76.5 0.9 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.13 103.8 12.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -129.79 160.64 63.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.538 0.685 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.3 Cg_endo -69.77 -166.29 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.376 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.21 104.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 411' ' ' PRO . 93.3 t -102.88 116.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.98 130.78 30.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 81.3 p -95.13 25.0 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -122.96 -35.85 2.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.8 p -119.52 -40.44 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.48 42.52 1.59 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.68 136.25 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.328 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -93.6 146.31 23.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -135.38 101.74 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.79 -35.87 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 26.76 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.5 t -125.03 -46.23 1.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -62.27 -35.88 80.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -61.65 -55.11 34.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.98 -51.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -66.72 -25.11 66.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -77.72 -16.64 58.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.48 -23.33 40.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -62.19 -45.18 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.63 -23.0 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -92.45 -31.83 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 39.3 p -100.8 25.9 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -107.07 32.14 7.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -117.7 169.21 9.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 t -173.01 127.53 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -178.24 -71.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.469 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.51 18.52 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 3.6 m -74.9 102.21 4.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 9.2 p -120.2 140.14 51.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.437 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 48.6 m -101.75 144.5 30.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 47.4 t -57.68 -53.79 54.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 52.64 79.96 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.463 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.1 m -134.37 147.67 50.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.6 m -126.27 142.25 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 141.57 135.82 3.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -123.76 131.44 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.923 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -144.79 160.64 46.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.571 0.701 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.691 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.73 -166.32 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.24 105.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 411' ' ' PRO . 95.1 t -107.25 114.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 9.0 t -52.03 130.7 30.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 74.0 p -95.23 25.16 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -122.75 -35.8 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.45 -40.79 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.99 43.78 1.36 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.11 134.38 55.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -95.31 147.88 23.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -135.64 99.72 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.03 -30.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -81.07 174.43 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -120.93 25.97 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.2 m -125.53 -45.19 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -64.24 -27.86 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -70.43 -56.53 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.71 -32.45 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -88.12 -25.03 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -72.48 -16.72 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -80.34 -23.44 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -62.09 -45.23 94.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.9 -22.67 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.48 -65.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 42.1 p -51.92 -49.59 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -100.18 56.47 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -103.92 140.97 36.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.5 p -83.67 76.67 9.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -147.35 68.1 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 94.87 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.639 2.226 . . . . 0.0 112.336 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.7 t -55.56 161.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.5 t -53.69 -30.24 42.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.503 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 88.1 p -173.31 147.9 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 47.7 m -145.16 145.17 31.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 80.28 110.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.447 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 16.1 p -93.74 153.26 18.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 110.798 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 8.0 t -93.92 -67.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 171.53 -165.46 38.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.452 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -122.93 89.89 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -73.95 160.65 81.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.6 Cg_endo -69.77 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.37 107.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 411' ' ' PRO . 83.2 t -108.26 116.08 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.121 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 25.8 t -52.1 127.02 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 22.5 p -95.24 25.96 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -121.88 -48.64 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.27 -26.44 8.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.29 81.98 1.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -151.21 124.75 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.96 141.83 28.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -134.58 103.24 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.5 -37.15 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -78.24 162.94 26.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -110.18 31.65 5.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.2 p -126.49 -50.06 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.92 -27.66 68.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -70.46 -54.74 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.72 -33.37 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 90.9 m -86.7 -25.1 24.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -71.95 -17.22 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.21 -22.43 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -63.17 -44.75 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 430' ' ' HIS . 11.9 tt -58.13 -22.23 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -95.48 -62.37 1.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 64.2 p -52.7 -44.41 66.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -63.32 -84.29 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.98 132.13 38.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.4 m 54.49 47.21 23.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -155.29 169.04 33.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 116.84 4.74 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.9 p -72.41 123.74 23.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 16.3 p -114.17 55.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.83 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.488 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.9 m -149.1 115.38 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.887 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.4 m -95.54 161.35 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -130.02 -152.26 7.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 16.9 p -138.87 168.54 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 4.4 t -89.36 96.88 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -179.56 89.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -53.12 114.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -113.16 159.19 35.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.617 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.7 Cg_endo -69.78 -166.31 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -50.46 109.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 411' ' ' PRO . 99.5 t -105.83 117.93 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.14 137.16 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.8 p -95.41 26.81 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.62 -40.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.5 -28.99 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.09 30.05 9.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -95.6 138.6 33.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -92.1 141.7 28.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -127.77 90.53 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 76.9 mt -51.78 -29.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -85.89 164.38 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -111.36 28.24 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 m -128.68 -39.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -71.56 -28.14 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.1 -44.47 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.8 mt -65.42 -27.62 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -90.53 -25.07 20.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.54 -23.93 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -70.37 -24.86 63.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -64.9 -59.27 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.6 tt -53.01 -28.42 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -77.0 -40.02 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 30.8 p -79.22 91.49 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -93.95 -179.38 38.78 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.02 97.56 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 10.5 p -127.67 50.25 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -153.17 68.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.466 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 135.21 29.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.348 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 51.0 m -84.24 62.93 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.3 m -99.87 -55.19 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.461 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -85.31 97.11 9.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.84 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 33.8 t -94.14 -31.3 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 104.73 -135.41 12.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 40.0 m -125.88 159.14 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.7 m -141.07 -177.48 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 81.92 76.94 1.06 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.444 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -109.34 70.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.72 160.71 67.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.75 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.667 2.244 . . . . 0.0 112.41 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.26 104.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 411' ' ' PRO . 76.5 t -102.36 124.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 11.2 t -60.52 127.49 31.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 19.0 p -96.18 29.48 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.77 -47.11 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.74 -27.2 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.16 82.7 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -156.18 128.07 7.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.11 146.61 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.56 100.71 4.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.27 -33.03 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -83.24 152.76 25.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -99.28 27.11 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.6 t -124.73 -49.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.28 -40.22 85.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -57.36 -54.44 46.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.83 -55.2 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -61.22 -25.56 67.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.169 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.65 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.5 t60 -80.43 -17.61 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -79.71 -21.72 44.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -63.97 -44.92 91.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -58.73 -21.54 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -95.69 -27.01 15.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 74.0 p -103.22 70.19 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 170.13 -100.92 0.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -100.64 155.85 17.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.369 . . . . 0.0 110.881 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.9 t 58.38 32.72 22.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.96 32.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 119.56 6.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.314 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.4 p -149.42 172.56 14.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.1 m 52.26 50.58 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.862 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 CA-C-O 119.16 -0.8 . . . . 0.0 112.497 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 4.3 p -129.88 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 103.79 146.21 15.96 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.5 p -87.2 85.28 7.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 3.5 t -134.58 112.93 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -135.11 149.43 19.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -101.49 87.48 3.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -124.69 160.63 52.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.52 0.676 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.77 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.661 2.241 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.25 109.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 63.7 t -105.64 124.32 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.4 t -60.15 127.45 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 43.9 p -95.33 25.2 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.19 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -124.09 -46.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.2 p -113.24 -27.25 8.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.846 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 90.41 78.86 1.35 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -151.63 132.49 14.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.31 148.36 26.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.02 95.87 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.84 -27.17 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -83.84 155.95 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.62 32.72 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.7 p -139.89 -45.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -61.16 -28.33 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.57 -55.21 5.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.18 -32.5 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.406 HG23 HH11 ' A' ' 432' ' ' ARG . 91.9 m -84.66 -26.36 27.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.9 t60 -74.36 -17.96 60.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.82 -22.88 52.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ARG . . . . . 0.406 HH11 HG23 ' A' ' 429' ' ' THR . 61.9 mtt180 -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.0 tt -60.43 -19.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -93.37 -61.55 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 67.0 p -59.55 97.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -145.14 167.63 27.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -124.89 81.81 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 2.3 m -122.74 103.57 8.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 111.44 179.26 20.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 166.27 28.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.647 2.231 . . . . 0.0 112.366 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.7 p -64.55 132.02 48.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 49.1 m -119.89 160.79 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.475 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.1 p -136.48 -176.25 4.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.851 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 60.0 p -149.04 148.39 29.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 151.54 68.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 32.1 t -97.98 97.13 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.0 t -105.4 151.66 23.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 133.35 118.66 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -108.59 116.02 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -91.45 160.66 36.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.544 0.687 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.79 -166.26 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -50.36 110.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 411' ' ' PRO . 70.4 t -104.84 131.82 53.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.5 128.48 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 51.3 p -95.99 25.11 4.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -126.97 -44.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.13 -26.88 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 88.92 84.41 1.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -154.68 123.8 6.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -77.57 144.79 37.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -135.24 96.88 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.57 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -84.32 159.29 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.09 24.79 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.0 p -134.26 -44.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -60.46 -26.72 66.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -78.26 -56.34 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.6 mt -54.34 -30.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 93.6 m -85.13 -25.56 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' HIS . . . . . 0.692 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.3 t60 -82.33 -18.23 42.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -78.52 -23.04 46.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -59.63 -45.49 91.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -57.29 -23.3 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -95.64 25.43 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 48.6 p -148.93 -173.16 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 68.14 91.52 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -138.24 157.95 45.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.891 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 31.1 m -82.44 63.16 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.76 -71.63 0.79 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 174.15 9.89 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.688 2.258 . . . . 0.0 112.378 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 41.2 t -91.37 -38.96 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.0 p 55.84 27.45 10.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.487 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.622 0.725 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.69 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.81 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.308 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.23 105.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 411' ' ' PRO . 80.5 t -106.78 115.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 40.3 t -53.12 127.2 23.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 70.6 p -96.54 31.46 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -125.86 -42.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.35 -33.11 3.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.07 86.19 1.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -158.06 124.92 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.07 143.92 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.053 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -133.18 97.14 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.85 -27.78 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -90.66 162.4 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -107.64 40.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 57.4 p -133.55 -54.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -72.37 -53.61 11.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.65 -37.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.5 m -74.95 -27.65 60.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.68 -25.35 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -68.35 -25.56 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -63.87 -60.46 3.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.8 tt -53.18 -28.34 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.839 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.613 0.721 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.73 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.22 107.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 411' ' ' PRO . 81.4 t -107.9 129.87 61.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 53.1 t -70.48 130.1 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 69.9 p -95.96 37.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -128.5 -41.08 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 16.8 p -123.1 -36.59 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.76 80.65 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -151.87 128.28 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -88.84 143.49 26.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -130.99 99.21 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.61 -37.73 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -88.13 152.25 22.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -96.03 42.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.9 p -131.77 -44.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -67.98 -26.59 66.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.86 -51.43 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.73 -32.55 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -82.79 -28.29 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -67.84 -24.49 65.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -69.38 -24.5 63.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -59.34 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 tt -53.11 -28.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 121.505 0.669 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.72 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.71 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.274 . . . . 0.0 112.345 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.19 106.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 411' ' ' PRO . 92.2 t -109.86 122.41 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.5 t -52.83 127.77 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 28.8 p -95.45 27.82 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -130.2 -45.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 22.0 p -116.69 -26.75 6.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.14 79.36 1.43 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.81 116.17 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.324 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.483 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -85.18 140.66 30.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.42 100.99 4.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -53.24 -29.68 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.45 168.96 13.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -111.02 26.88 10.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 96.1 p -125.06 -50.08 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -59.29 -36.11 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.42 -57.29 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.82 -51.62 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -65.66 -25.69 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.67 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.4 t60 -75.74 -19.26 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.44 -23.05 43.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -59.01 -45.94 89.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.9 tt -51.61 -30.02 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.641 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.29 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.25 106.61 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 411' ' ' PRO . 91.7 t -103.75 119.78 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.7 t -52.07 124.66 13.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 73.3 p -95.52 31.78 1.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.43 -43.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.67 -28.92 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 94.11 84.4 1.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -156.44 124.71 5.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.92 141.54 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.17 101.19 5.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.14 -35.49 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -80.83 157.18 25.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -102.09 26.03 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.9 t -125.69 -49.6 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.28 -34.93 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -63.08 -59.54 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.75 -48.42 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 30.1 m -65.74 -31.57 72.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -75.07 -18.33 60.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -79.53 -23.3 42.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 32.6 mtp85 -58.96 -46.18 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -53.6 -27.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.82 -166.27 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.286 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.3 106.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 411' ' ' PRO . 61.2 t -102.79 131.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.48 126.59 28.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 31.8 p -95.52 28.07 3.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -129.72 -45.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.23 -28.17 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.0 84.83 1.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -157.36 127.8 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.28 28.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.97 100.19 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.95 -31.0 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 40.7 mtm-85 -82.54 154.91 24.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -103.24 26.08 8.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 6.9 t -129.44 -40.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.42 -29.83 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.66 -52.83 22.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.63 -35.86 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.3 m -83.3 -25.54 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -69.36 -18.21 63.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.06 -22.95 44.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -59.6 -45.88 90.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -55.88 -25.02 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.2 mttp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.5 Cg_endo -69.71 -166.27 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.393 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.25 106.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 411' ' ' PRO . 87.8 t -103.7 133.61 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.95 126.97 31.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 18.1 p -96.59 29.99 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.01 -43.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.87 -31.36 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 98.64 85.3 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.471 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -157.92 128.55 6.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.3 26.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.84 103.17 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.47 -31.06 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -80.31 163.86 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -109.49 29.2 7.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 48.0 t -123.93 -61.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -52.56 -42.43 64.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.4 -49.98 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.9 mt -67.41 -32.39 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.533 HG23 ' NH1' ' A' ' 432' ' ' ARG . 2.6 m -94.34 20.43 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.678 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -116.35 -18.63 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.6 -23.48 42.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . 0.533 ' NH1' HG23 ' A' ' 429' ' ' THR . 1.4 mpt_? -58.6 -46.3 87.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -52.24 -29.24 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.58 0.705 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.79 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.22 111.61 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 411' ' ' PRO . 79.0 t -110.22 118.96 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 34.3 t -55.37 130.76 43.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 23.3 p -99.81 29.06 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -127.2 -43.8 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 30.9 p -117.03 -28.34 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.76 87.09 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -160.11 127.38 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.22 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.54 101.15 4.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.28 -32.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -79.21 152.07 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -102.01 26.44 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 t -125.38 -46.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.69 -27.95 68.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -70.24 -51.23 32.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.93 -31.36 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.9 m -88.38 -25.12 22.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.5 t60 -71.99 -16.55 62.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.13 -23.6 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -45.04 95.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.5 tt -55.79 -25.11 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.901 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.535 0.683 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.639 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.78 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.23 106.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -102.97 123.36 56.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 17.8 t -58.25 125.51 23.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.3 p -95.91 29.79 2.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -126.31 -46.37 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.8 p -116.88 -28.56 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.32 86.92 1.78 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -160.11 125.67 4.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.56 145.69 27.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.17 102.18 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.7 mt -58.72 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 27.7 mtm-85 -86.71 150.81 23.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -96.87 26.37 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.1 p -125.81 -48.46 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.06 -33.23 72.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.84 -57.46 8.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.18 -48.78 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.4 m -67.37 -25.44 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.4 t60 -79.64 -16.73 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.99 -23.38 38.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -61.76 -44.98 95.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.08 -24.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.862 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.76 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.388 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.2 105.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 411' ' ' PRO . 86.5 t -103.16 118.66 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.5 t -57.73 125.73 24.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 60.1 p -95.61 28.51 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -123.15 -44.96 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.8 -30.03 5.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 97.28 82.47 1.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -157.45 129.77 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.335 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -91.11 141.54 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.075 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -130.17 102.9 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.81 -27.13 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -84.77 152.37 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -101.9 26.24 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 72.4 p -125.62 -46.68 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.83 -26.3 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -71.69 -48.48 47.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.26 -29.66 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.1 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -90.27 -25.17 20.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.659 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -69.67 -16.7 63.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -81.05 -23.22 38.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -61.97 -44.85 95.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.06 -24.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 26.2 mttp . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.8 -166.29 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.315 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.25 104.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -100.66 120.92 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.87 126.68 28.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 71.6 p -95.69 25.35 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -121.98 -40.65 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 24.4 p -118.62 -31.78 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.14 79.56 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -155.63 130.77 9.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.4 146.96 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.03 100.21 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.35 -25.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 144.38 30.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -96.62 26.01 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 4.9 m -131.69 -40.74 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.01 -33.13 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.3 -56.66 10.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.7 -45.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -71.49 -33.92 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -66.8 -16.55 64.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.06 -23.51 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -61.59 -45.15 95.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -56.06 -24.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.888 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.572 0.701 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.673 2.249 . . . . 0.0 112.317 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.16 104.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.6 t -101.06 120.78 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.38 126.59 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 17.7 p -96.82 31.69 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -132.3 -44.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.2 p -114.16 -28.85 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.44 82.92 1.49 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -156.91 130.01 7.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.68 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -137.02 100.64 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.32 -25.59 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -81.85 148.59 28.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -99.88 25.87 6.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 75.1 p -131.6 -41.36 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -67.66 -34.17 76.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -66.18 -55.52 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -52.48 -42.46 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.0 m -73.84 -33.92 64.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.661 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -69.87 -17.1 63.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.75 -22.62 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -62.66 -44.73 95.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.41 -24.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 29.1 mttm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.86 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.662 2.242 . . . . 0.0 112.332 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.25 105.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.3 t -99.84 141.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.3 t -78.08 128.09 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -95.59 27.87 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -127.96 -42.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.5 p -117.62 -30.3 5.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.59 80.94 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.529 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -154.64 130.17 9.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.39 26.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.86 98.08 3.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.68 -25.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -84.07 156.1 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 31.66 4.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 87.3 p -138.5 -44.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.49 -27.17 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -74.19 -57.57 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.5 mt -51.93 -41.0 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.5 m -74.94 -27.5 60.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -74.76 -16.77 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.61 -23.16 39.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -62.14 -45.09 94.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.11 -23.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.523 0.677 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.82 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.27 104.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.8 t -103.35 132.15 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.61 127.95 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.2 p -95.98 25.07 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -120.77 -46.32 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.99 -29.22 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 95.61 81.18 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -153.68 127.93 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.46 148.15 25.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.28 100.24 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.26 -34.53 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -82.58 155.47 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -103.78 36.43 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.1 t -132.51 -45.88 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -68.03 -28.11 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -70.83 -51.04 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.48 -32.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.4 m -87.21 -25.14 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -70.95 -16.86 62.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -80.48 -22.97 40.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -62.46 -44.96 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -57.75 -22.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.849 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 37.5 mttt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.538 0.685 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.3 Cg_endo -69.77 -166.29 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.376 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.21 104.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 411' ' ' PRO . 93.3 t -102.88 116.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.98 130.78 30.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 81.3 p -95.13 25.0 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -122.96 -35.85 2.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.8 p -119.52 -40.44 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.48 42.52 1.59 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.68 136.25 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.328 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -93.6 146.31 23.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -135.38 101.74 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.79 -35.87 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 26.76 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.5 t -125.03 -46.23 1.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -62.27 -35.88 80.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -61.65 -55.11 34.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.98 -51.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -66.72 -25.11 66.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -77.72 -16.64 58.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.48 -23.33 40.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -62.19 -45.18 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.63 -23.0 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.915 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.571 0.701 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.691 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.73 -166.32 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.24 105.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 411' ' ' PRO . 95.1 t -107.25 114.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 9.0 t -52.03 130.7 30.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 74.0 p -95.23 25.16 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -122.75 -35.8 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.45 -40.79 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.99 43.78 1.36 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.11 134.38 55.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -95.31 147.88 23.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -135.64 99.72 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.03 -30.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -81.07 174.43 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -120.93 25.97 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.2 m -125.53 -45.19 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -64.24 -27.86 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -70.43 -56.53 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.71 -32.45 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -88.12 -25.03 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -72.48 -16.72 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -80.34 -23.44 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -62.09 -45.23 94.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.9 -22.67 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.841 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.592 0.711 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.6 Cg_endo -69.77 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.37 107.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 411' ' ' PRO . 83.2 t -108.26 116.08 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.121 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 25.8 t -52.1 127.02 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 22.5 p -95.24 25.96 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -121.88 -48.64 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.27 -26.44 8.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.29 81.98 1.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -151.21 124.75 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.96 141.83 28.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -134.58 103.24 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.5 -37.15 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -78.24 162.94 26.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -110.18 31.65 5.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.2 p -126.49 -50.06 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.92 -27.66 68.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -70.46 -54.74 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.72 -33.37 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 90.9 m -86.7 -25.1 24.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -71.95 -17.22 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.21 -22.43 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -63.17 -44.75 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 430' ' ' HIS . 11.9 tt -58.13 -22.23 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.867 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.566 0.698 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.617 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.7 Cg_endo -69.78 -166.31 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -50.46 109.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 411' ' ' PRO . 99.5 t -105.83 117.93 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.14 137.16 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.8 p -95.41 26.81 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.62 -40.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.5 -28.99 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.09 30.05 9.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -95.6 138.6 33.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -92.1 141.7 28.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -127.77 90.53 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 76.9 mt -51.78 -29.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -85.89 164.38 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -111.36 28.24 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 m -128.68 -39.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -71.56 -28.14 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.1 -44.47 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.8 mt -65.42 -27.62 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -90.53 -25.07 20.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.54 -23.93 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -70.37 -24.86 63.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -64.9 -59.27 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.6 tt -53.01 -28.42 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.587 0.708 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.75 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.667 2.244 . . . . 0.0 112.41 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.26 104.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 411' ' ' PRO . 76.5 t -102.36 124.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 11.2 t -60.52 127.49 31.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 19.0 p -96.18 29.48 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.77 -47.11 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.74 -27.2 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.16 82.7 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -156.18 128.07 7.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.11 146.61 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.56 100.71 4.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.27 -33.03 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -83.24 152.76 25.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -99.28 27.11 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.6 t -124.73 -49.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.28 -40.22 85.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -57.36 -54.44 46.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.83 -55.2 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -61.22 -25.56 67.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.169 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.65 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.5 t60 -80.43 -17.61 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -79.71 -21.72 44.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -63.97 -44.92 91.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -58.73 -21.54 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.52 0.676 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.77 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.661 2.241 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.25 109.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 63.7 t -105.64 124.32 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.4 t -60.15 127.45 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 43.9 p -95.33 25.2 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.19 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -124.09 -46.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.2 p -113.24 -27.25 8.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.846 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 90.41 78.86 1.35 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -151.63 132.49 14.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.31 148.36 26.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.02 95.87 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.84 -27.17 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -83.84 155.95 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.62 32.72 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.7 p -139.89 -45.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.16 -28.33 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.57 -55.21 5.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.18 -32.5 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . 0.406 HG23 HH11 ' A' ' 432' ' ' ARG . 91.9 m -84.66 -26.36 27.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.9 t60 -74.36 -17.96 60.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.82 -22.88 52.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . 0.406 HH11 HG23 ' A' ' 429' ' ' THR . 61.9 mtt180 -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.0 tt -60.43 -19.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.544 0.687 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.79 -166.26 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -50.36 110.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 411' ' ' PRO . 70.4 t -104.84 131.82 53.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.5 128.48 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 51.3 p -95.99 25.11 4.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -126.97 -44.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.13 -26.88 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 88.92 84.41 1.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -154.68 123.8 6.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -77.57 144.79 37.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -135.24 96.88 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.57 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -84.32 159.29 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.09 24.79 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.0 p -134.26 -44.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -60.46 -26.72 66.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -78.26 -56.34 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.6 mt -54.34 -30.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 93.6 m -85.13 -25.56 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' HIS . . . . . 0.692 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.3 t60 -82.33 -18.23 42.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -78.52 -23.04 46.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -59.63 -45.49 91.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -57.29 -23.3 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.865 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 27.7 m -132.41 58.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.357 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.5 m -102.51 33.02 3.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 92.09 -81.71 1.18 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 m 59.43 46.03 12.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.879 0.371 . . . . 0.0 110.88 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 22.6 m -143.86 157.34 44.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.85 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 77.63 53.77 4.89 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.478 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -64.65 118.5 8.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.957 0.408 . . . . 0.0 110.867 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -94.39 160.71 31.21 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.69 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.81 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.692 2.261 . . . . 0.0 112.308 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.23 105.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 411' ' ' PRO . 80.5 t -106.78 115.02 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 40.3 t -53.12 127.2 23.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 70.6 p -96.54 31.46 2.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -125.86 -42.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.35 -33.11 3.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 101.07 86.19 1.91 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -158.06 124.92 4.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.07 143.92 27.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.053 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -133.18 97.14 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 72.9 mt -55.85 -27.78 22.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.108 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 67.0 mtm180 -90.66 162.4 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 7.6 ttmm -107.64 40.33 1.73 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 57.4 p -133.55 -54.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -72.37 -53.61 11.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.2 mt -57.65 -37.95 61.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.086 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.5 m -74.95 -27.65 60.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -68.68 -25.35 64.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -68.35 -25.56 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -63.87 -60.46 3.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.866 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.8 tt -53.18 -28.34 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -79.17 -64.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 78.0 p -55.87 103.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -64.04 -35.53 92.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.509 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -123.81 134.71 53.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.866 0.365 . . . . 0.0 110.893 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 5.3 t -173.01 120.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.11 27.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.491 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -40.39 5.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 53.7 p -60.36 -36.99 79.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.3 p -96.44 147.49 23.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.853 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 119.171 -0.794 . . . . 0.0 112.501 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 15.7 t -112.56 86.22 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.905 0.383 . . . . 0.0 110.864 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 16.9 t -98.69 -52.46 3.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.883 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -81.62 174.15 54.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.519 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 11.2 p -151.13 108.78 3.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 110.817 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 -56.91 3.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.829 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -102.78 165.1 16.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -169.89 150.92 3.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 110.886 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -87.2 160.65 48.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.613 0.721 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.68 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.73 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.662 2.241 . . . . 0.0 112.345 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.22 107.83 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 411' ' ' PRO . 81.4 t -107.9 129.87 61.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 53.1 t -70.48 130.1 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 69.9 p -95.96 37.1 1.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.123 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -128.5 -41.08 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 16.8 p -123.1 -36.59 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 104.76 80.65 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.463 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -151.87 128.28 10.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -88.84 143.49 26.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.142 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -130.99 99.21 4.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.61 -37.73 47.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.137 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -88.13 152.25 22.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -96.03 42.14 1.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.9 p -131.77 -44.76 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -67.98 -26.59 66.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.846 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.86 -51.43 16.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.5 mt -57.73 -32.55 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -82.79 -28.29 30.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -67.84 -24.49 65.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.804 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -69.38 -24.5 63.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.26 -59.34 3.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.7 tt -53.11 -28.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -81.09 -42.2 21.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.876 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 74.2 p -85.42 84.1 7.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.142 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -104.87 75.34 0.24 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.519 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -134.07 41.07 3.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.875 0.369 . . . . 0.0 110.902 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 18.9 m -115.33 52.55 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -84.54 170.21 46.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.471 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 146.03 59.5 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.382 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 t 52.55 50.7 17.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.857 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.7 p -128.12 162.91 25.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.488 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 8.1 t 62.36 31.61 17.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.877 0.37 . . . . 0.0 110.84 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 72.4 m -114.58 -66.96 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 94.59 66.71 1.01 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.474 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 7.5 t -68.98 134.13 49.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.832 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 3.2 m -61.8 167.44 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.85 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -138.66 144.39 15.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.521 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.14 27.9 8.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.896 0.379 . . . . 0.0 110.864 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -98.82 160.64 27.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.505 0.669 . . . . 0.0 110.91 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.72 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.71 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.274 . . . . 0.0 112.345 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.19 106.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 411' ' ' PRO . 92.2 t -109.86 122.41 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.5 t -52.83 127.77 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.899 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 28.8 p -95.45 27.82 3.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -130.2 -45.74 1.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 22.0 p -116.69 -26.75 6.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.14 79.36 1.43 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -142.81 116.17 9.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.779 0.324 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.483 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -85.18 140.66 30.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.116 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -135.42 100.99 4.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -53.24 -29.68 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.45 168.96 13.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -111.02 26.88 10.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 96.1 p -125.06 -50.08 1.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -59.29 -36.11 74.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -61.42 -57.29 12.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.0 mt -51.82 -51.62 26.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.136 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -65.66 -25.69 67.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.67 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.4 t60 -75.74 -19.26 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -79.44 -23.05 43.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.1 mtm180 -59.01 -45.94 89.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.9 tt -51.61 -30.02 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -89.1 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 39.9 p -52.12 -62.97 1.3 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.151 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 137.93 -73.03 0.43 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.425 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -169.4 110.14 0.46 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.8 m -101.48 69.87 1.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.818 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.45 175.76 7.01 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 105.09 1.42 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.688 2.259 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.9 t -69.35 112.33 5.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.867 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 14.5 t -110.03 74.85 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.86 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-O 119.112 -0.826 . . . . 0.0 112.506 -179.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 3.4 m -117.37 93.18 4.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.809 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.1 m -164.44 162.59 22.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 145.88 59.46 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 66.4 m -140.78 -179.59 6.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.869 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 59.8 p -157.07 154.73 29.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -170.33 81.69 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -73.15 176.68 5.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.947 0.404 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -132.54 160.73 67.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.553 0.692 . . . . 0.0 110.891 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.641 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.29 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.25 106.61 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 411' ' ' PRO . 91.7 t -103.75 119.78 52.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.7 t -52.07 124.66 13.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 73.3 p -95.52 31.78 1.94 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.184 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.43 -43.55 0.84 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.9 p -116.67 -28.92 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.905 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 94.11 84.4 1.61 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.7 mttt -156.44 124.71 5.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.894 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -83.92 141.54 31.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.106 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -133.17 101.19 5.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.14 -35.49 48.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -80.83 157.18 25.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -102.09 26.03 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.9 t -125.69 -49.6 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -59.28 -34.93 72.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -63.08 -59.54 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.9 mt -51.75 -48.42 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 30.1 m -65.74 -31.57 72.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -75.07 -18.33 60.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -79.53 -23.3 42.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 32.6 mtp85 -58.96 -46.18 88.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.671 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -53.6 -27.71 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -86.24 -41.05 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 73.6 p -66.36 -26.97 67.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -98.64 -86.5 1.87 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -68.26 170.6 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.363 . . . . 0.0 110.895 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 58.8 m -95.66 -67.12 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.866 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -136.85 173.71 21.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.496 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -26.99 26.74 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.683 2.255 . . . . 0.0 112.334 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 13.3 p -130.1 158.9 38.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 p -158.4 125.17 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 119.113 -0.826 . . . . 0.0 112.502 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 20.2 m -106.94 49.69 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.882 0.372 . . . . 0.0 110.867 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.8 t -153.22 155.37 36.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -170.08 49.19 0.2 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 94.0 p -143.01 127.35 17.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.894 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 20.0 p -88.49 -27.02 21.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 111.76 -156.43 15.57 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -113.3 132.41 55.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.918 0.39 . . . . 0.0 110.912 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -154.33 160.72 30.63 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.644 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.82 -166.27 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.675 2.25 . . . . 0.0 112.286 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.3 106.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 411' ' ' PRO . 61.2 t -102.79 131.82 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.145 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.48 126.59 28.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 31.8 p -95.52 28.07 3.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -129.72 -45.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.23 -28.17 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.901 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.0 84.83 1.49 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt -157.36 127.8 6.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.77 0.319 . . . . 0.0 110.937 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.22 143.28 28.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.97 100.19 4.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.95 -31.0 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 40.7 mtm-85 -82.54 154.91 24.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -103.24 26.08 8.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 6.9 t -129.44 -40.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.841 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -69.42 -29.83 67.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -69.66 -52.83 22.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -55.63 -35.86 40.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.3 m -83.3 -25.54 31.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.155 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.682 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -69.36 -18.21 63.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.06 -22.95 44.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 47.0 mtp180 -59.6 -45.88 90.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.851 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -55.88 -25.02 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -87.47 -30.78 20.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.851 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 71.5 p -81.64 78.27 8.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.16 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -96.68 67.05 0.95 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.441 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -113.98 55.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.877 0.37 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.4 t -121.81 -49.48 2.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -152.23 -72.37 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.445 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 115.45 4.1 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.696 2.264 . . . . 0.0 112.348 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.3 t -146.4 151.13 36.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 8.5 t -100.45 47.63 0.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-O 119.179 -0.789 . . . . 0.0 112.521 -179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.7 p -151.72 152.17 32.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.898 0.38 . . . . 0.0 110.858 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 2.0 t -93.12 127.02 38.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -174.08 -59.59 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.4 m -116.44 133.52 55.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 0.0 110.883 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 1.4 t -115.32 -29.55 6.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 110.56 105.53 2.9 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -110.67 35.94 3.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 0.0 110.88 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -99.24 160.65 27.04 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.534 0.683 . . . . 0.0 110.899 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.646 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.5 Cg_endo -69.71 -166.27 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.668 2.245 . . . . 0.0 112.393 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.25 106.6 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 411' ' ' PRO . 87.8 t -103.7 133.61 47.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 14.2 t -69.95 126.97 31.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 18.1 p -96.59 29.99 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.01 -43.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.87 -31.36 4.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 98.64 85.3 1.82 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.471 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -157.92 128.55 6.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.743 0.306 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -90.86 143.3 26.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.84 103.17 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 77.5 mt -58.47 -31.06 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -80.31 163.86 23.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -109.49 29.2 7.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 48.0 t -123.93 -61.48 1.36 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -52.56 -42.43 64.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -53.4 -49.98 66.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.839 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 72.9 mt -67.41 -32.39 57.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.533 HG23 ' NH1' ' A' ' 432' ' ' ARG . 2.6 m -94.34 20.43 8.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.189 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.678 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.6 t60 -116.35 -18.63 10.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -79.6 -23.48 42.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . 0.533 ' NH1' HG23 ' A' ' 429' ' ' THR . 1.4 mpt_? -58.6 -46.3 87.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.678 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -52.24 -29.24 12.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -87.69 -47.51 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 66.5 p -74.28 74.44 1.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 173.04 74.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.33 175.5 10.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 0.0 110.88 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.34 59.52 5.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.882 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 104.25 69.14 0.77 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.522 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 170.71 15.93 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.733 2.288 . . . . 0.0 112.345 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 37.9 m -65.78 99.67 0.48 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 5.5 t -113.15 143.11 44.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.155 -0.803 . . . . 0.0 112.49 -179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.8 t -58.04 140.62 52.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.88 0.371 . . . . 0.0 110.821 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.1 t -95.65 90.25 5.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -83.2 -139.82 3.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.534 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 20.0 m -150.88 135.86 17.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.885 0.374 . . . . 0.0 110.845 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 29.9 t -97.82 -51.81 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.888 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 135.68 145.25 5.07 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -70.41 101.43 1.96 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.949 0.404 . . . . 0.0 110.921 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -117.13 160.66 36.39 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.58 0.705 . . . . 0.0 110.888 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.79 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.22 111.61 0.55 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 411' ' ' PRO . 79.0 t -110.22 118.96 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.134 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 34.3 t -55.37 130.76 43.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 23.3 p -99.81 29.06 4.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.13 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -127.2 -43.8 1.62 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 30.9 p -117.03 -28.34 6.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.76 87.09 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -160.11 127.38 4.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.6 144.22 26.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.101 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -134.54 101.15 4.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.8 mt -58.28 -32.27 44.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -79.21 152.07 30.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 8.5 ttmm -102.01 26.44 7.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.7 t -125.38 -46.18 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.69 -27.95 68.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.825 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -70.24 -51.23 32.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.93 -31.36 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.171 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.9 m -88.38 -25.12 22.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.657 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.5 t60 -71.99 -16.55 62.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.816 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -81.13 -23.6 38.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.47 -45.04 95.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.5 tt -55.79 -25.11 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.141 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -95.51 -28.84 14.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 67.2 p -104.52 40.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -98.8 -50.89 1.45 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -58.51 157.47 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 110.938 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 73.6 m -93.79 44.12 1.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -165.38 69.14 0.2 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.461 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.41 11.02 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.669 2.246 . . . . 0.0 112.342 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.9 t -117.92 119.47 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.833 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.6 p -78.44 -35.38 46.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.836 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.1 -0.833 . . . . 0.0 112.493 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.04 109.8 18.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 21.9 p -159.26 168.53 26.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.862 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 139.49 -159.03 25.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 73.8 p -151.12 115.91 5.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.892 0.377 . . . . 0.0 110.837 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 60.1 p -96.41 33.16 1.84 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.846 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -176.07 -137.31 2.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -162.66 139.87 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -134.35 160.66 67.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.535 0.683 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.639 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.78 -166.32 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.334 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.23 106.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -102.97 123.36 56.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 17.8 t -58.25 125.51 23.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 64.3 p -95.91 29.79 2.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -126.31 -46.37 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.8 p -116.88 -28.56 6.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.32 86.92 1.78 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -160.11 125.67 4.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -85.56 145.69 27.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.089 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -136.17 102.18 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.7 mt -58.72 -28.84 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 27.7 mtm-85 -86.71 150.81 23.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -96.87 26.37 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.1 p -125.81 -48.46 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.831 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.06 -33.23 72.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.84 -57.46 8.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.18 -48.78 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.4 m -67.37 -25.44 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.66 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.4 t60 -79.64 -16.73 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -80.99 -23.38 38.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -61.76 -44.98 95.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.08 -24.81 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.133 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -94.36 -27.01 16.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 76.8 p -104.07 30.55 5.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -92.64 153.02 21.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.45 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -119.31 143.73 47.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.915 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.6 m 58.71 28.48 17.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -139.65 -74.61 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -17.21 37.69 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.622 2.215 . . . . 0.0 112.362 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.37 110.66 20.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.806 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.81 -62.19 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.83 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.5 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.446 -0.261 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 13.2 m -95.06 -51.92 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.361 . . . . 0.0 110.875 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 4.4 m -83.13 178.42 8.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.847 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 101.52 160.95 27.02 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.481 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 61.7 m -97.82 82.92 3.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.856 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 18.6 m -113.78 -178.36 3.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.853 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 105.2 -94.72 1.03 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.534 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 57.95 45.37 18.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.928 0.394 . . . . 0.0 110.89 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -134.79 160.7 67.45 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.583 0.706 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.76 -166.3 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.667 2.245 . . . . 0.0 112.388 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.2 105.44 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 411' ' ' PRO . 86.5 t -103.16 118.66 50.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.091 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.5 t -57.73 125.73 24.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 60.1 p -95.61 28.51 2.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.128 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -123.15 -44.96 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.892 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.9 p -116.8 -30.03 5.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 97.28 82.47 1.64 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.526 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -157.45 129.77 7.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.805 0.335 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -91.11 141.54 28.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.075 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -130.17 102.9 6.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.3 mt -59.81 -27.13 37.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.155 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -84.77 152.37 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -101.9 26.24 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 72.4 p -125.62 -46.68 1.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -66.83 -26.3 66.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -71.69 -48.48 47.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.897 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.3 mt -60.26 -29.66 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.1 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 94.7 m -90.27 -25.17 20.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.659 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -69.67 -16.7 63.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -81.05 -23.22 38.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 -61.97 -44.85 95.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.06 -24.91 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.119 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -92.35 -35.42 13.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 46.7 p -91.8 44.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.112 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -130.61 -162.05 10.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -129.81 48.76 2.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.863 0.363 . . . . 0.0 110.853 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 57.7 p -88.78 59.9 5.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -176.04 -171.36 39.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.453 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -48.18 0.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.675 2.25 . . . . 0.0 112.338 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.7 m -60.68 132.61 54.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.2 p -121.56 -58.34 1.77 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.488 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.239 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 19.1 m -67.94 112.81 5.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 110.844 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.3 p -159.34 165.2 33.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.845 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 105.93 58.08 0.64 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 6.2 m -65.39 130.84 44.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 110.871 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 29.7 t -144.31 109.25 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.859 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -167.09 105.12 0.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -130.17 156.69 44.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.929 0.395 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -106.87 160.68 25.44 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.566 0.698 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.632 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.4 Cg_endo -69.8 -166.29 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.667 2.244 . . . . 0.0 112.315 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.25 104.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.7 t -100.66 120.92 50.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.099 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 6.7 t -56.87 126.68 28.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 71.6 p -95.69 25.35 4.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -121.98 -40.65 2.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.908 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 24.4 p -118.62 -31.78 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 96.14 79.56 1.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.494 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -155.63 130.77 9.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.4 146.96 27.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.089 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.03 100.21 4.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.0 mt -60.35 -25.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.43 144.38 30.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 6.4 ttmm -96.62 26.01 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 4.9 m -131.69 -40.74 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -69.01 -33.13 73.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.3 -56.66 10.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.8 mt -51.7 -45.24 37.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.179 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -71.49 -33.92 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.144 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.6 t60 -66.8 -16.55 64.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -81.06 -23.51 38.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -61.59 -45.15 95.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -56.06 -24.77 18.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.114 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -89.46 -28.6 19.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.876 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 75.2 p -95.6 69.14 2.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.137 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 177.33 -118.44 0.63 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.481 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.08 -53.54 5.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 4.0 t 62.97 49.55 3.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -153.24 69.17 0.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -33.88 15.72 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.699 2.266 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 7.7 p -88.8 -33.15 17.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.861 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.4 m 61.01 53.11 3.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.852 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 CA-C-O 119.105 -0.831 . . . . 0.0 112.476 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.531 -0.228 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 91.6 p -109.1 125.14 51.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.911 0.386 . . . . 0.0 110.881 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.1 m -114.71 134.85 54.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.87 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 152.46 82.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.0 m -122.89 154.07 38.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.924 0.392 . . . . 0.0 110.852 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.5 p -131.12 78.62 1.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.836 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -108.77 101.0 1.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -118.26 69.29 0.79 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 110.893 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.1 mtmt -115.7 160.7 33.88 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.81 -166.33 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.673 2.249 . . . . 0.0 112.317 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.16 104.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 411' ' ' PRO . 89.6 t -101.06 120.78 51.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 3.7 t -54.38 126.59 23.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 17.7 p -96.82 31.69 2.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -132.3 -44.52 0.93 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 31.2 p -114.16 -28.85 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.921 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.44 82.92 1.49 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.49 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -156.91 130.01 7.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.772 0.32 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.03 144.68 27.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.068 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -137.02 100.64 4.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.9 mt -60.32 -25.59 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.071 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -81.85 148.59 28.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -99.88 25.87 6.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 75.1 p -131.6 -41.36 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -67.66 -34.17 76.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.839 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -66.18 -55.52 15.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.846 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 70.7 mt -52.48 -42.46 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.0 m -73.84 -33.92 64.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.661 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -69.87 -17.1 63.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.75 -22.62 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 53.3 mtp85 -62.66 -44.73 95.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -56.41 -24.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -92.33 -42.32 9.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 79.0 p -88.92 103.1 15.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.162 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 145.5 83.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.448 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -91.37 68.17 5.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.362 . . . . 0.0 110.862 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 9.1 t -173.46 118.47 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.863 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -166.61 -173.52 35.04 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.497 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.66 -22.69 32.19 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.258 . . . . 0.0 112.368 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.3 p -54.44 131.73 42.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.9 p -131.35 79.51 1.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.481 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.4 p -95.03 -39.8 9.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.357 . . . . 0.0 110.882 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 83.7 p -62.14 -35.07 77.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -94.48 23.78 30.61 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 2.8 t -114.65 92.44 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.8 p -94.74 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 177.9 -165.88 35.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.539 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.45 57.34 3.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 29.1 mttm -106.09 160.73 25.16 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.587 0.708 . . . . 0.0 110.871 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.3 Cg_endo -69.86 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.662 2.242 . . . . 0.0 112.332 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -50.25 105.01 0.08 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.3 t -99.84 141.81 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.3 t -78.08 128.09 33.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 62.2 p -95.59 27.87 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -127.96 -42.07 1.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.5 p -117.62 -30.3 5.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 92.59 80.94 1.46 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.529 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -154.64 130.17 9.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 0.0 110.87 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.84 147.39 26.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.106 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -136.86 98.08 3.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.88 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.6 mt -56.68 -25.9 22.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.146 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -84.07 156.1 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 31.66 4.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 87.3 p -138.5 -44.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.49 -27.17 69.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -74.19 -57.57 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 73.5 mt -51.93 -41.0 29.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.12 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.5 m -74.94 -27.5 60.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.19 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.651 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -74.76 -16.77 60.71 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -80.61 -23.16 39.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -62.14 -45.09 94.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.11 -23.58 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.119 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 18.6 m-70 -89.02 -37.62 15.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 66.8 p -81.36 85.92 6.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -109.08 -170.62 20.74 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.47 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -121.13 27.11 8.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 30.6 t -54.21 -47.66 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -76.33 171.05 54.84 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 104.66 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 0.0 112.336 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.8 p -59.57 171.36 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 7.4 t 53.9 37.24 26.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.833 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.148 -0.807 . . . . 0.0 112.518 179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 26.1 m -80.07 145.25 32.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.854 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 2.1 m -154.49 115.44 4.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -129.8 23.35 4.74 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.468 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.3 p -78.08 97.0 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 23.5 m -105.35 -55.03 2.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 97.6 88.39 1.87 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -109.74 60.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -84.35 160.7 56.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.523 0.677 . . . . 0.0 110.924 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.676 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.5 Cg_endo -69.82 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.672 2.248 . . . . 0.0 112.328 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.27 104.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 411' ' ' PRO . 66.8 t -103.35 132.15 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.61 127.95 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 35.2 p -95.98 25.07 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -120.77 -46.32 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 29.6 p -115.99 -29.22 6.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.929 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 95.61 81.18 1.55 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -153.68 127.93 9.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 0.0 110.931 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.46 148.15 25.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -137.28 100.24 4.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 75.3 mt -57.26 -34.53 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 46.2 mtm-85 -82.58 155.47 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -103.78 36.43 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 33.1 t -132.51 -45.88 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.827 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -68.03 -28.11 67.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -70.83 -51.04 29.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 65.4 mt -57.48 -32.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.4 m -87.21 -25.14 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -70.95 -16.86 62.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.872 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -80.48 -22.97 40.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -62.46 -44.96 95.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.846 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -57.75 -22.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.143 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -92.33 -48.24 6.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 75.1 p -72.4 99.01 2.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -165.67 -63.66 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.485 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -59.25 -64.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 87.9 p -107.06 27.58 8.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -63.06 -71.52 0.82 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 91.93 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.8 t -152.91 157.31 40.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 6.6 p -92.99 -46.68 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.463 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 57.3 p -113.99 102.11 9.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 7.6 t -161.21 176.71 10.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.871 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 72.91 128.59 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.5 t -152.95 118.03 5.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 30.1 t -85.54 77.85 9.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.85 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -94.95 76.5 0.9 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.531 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -83.13 103.8 12.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -129.79 160.64 63.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.538 0.685 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.664 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.3 Cg_endo -69.77 -166.29 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.376 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -50.21 104.35 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 411' ' ' PRO . 93.3 t -102.88 116.04 45.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 8.8 t -51.98 130.78 30.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 81.3 p -95.13 25.0 4.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.139 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -122.96 -35.85 2.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.8 p -119.52 -40.44 2.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.48 42.52 1.59 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.68 136.25 53.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.328 . . . . 0.0 110.926 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -93.6 146.31 23.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.128 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -135.38 101.74 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.925 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.79 -35.87 58.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 37.9 mtt85 -81.48 152.22 27.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.99 26.76 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.919 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 14.5 t -125.03 -46.23 1.83 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -62.27 -35.88 80.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.806 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -61.65 -55.11 34.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.4 mt -52.98 -51.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -66.72 -25.11 66.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -77.72 -16.64 58.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.48 -23.33 40.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 54.4 mmm-85 -62.19 -45.18 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.858 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.63 -23.0 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.102 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -92.45 -31.83 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 39.3 p -100.8 25.9 7.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -107.07 32.14 7.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -117.7 169.21 9.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.1 t -173.01 127.53 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -178.24 -71.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.469 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -32.51 18.52 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.686 2.257 . . . . 0.0 112.332 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 3.6 m -74.9 102.21 4.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 9.2 p -120.2 140.14 51.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.812 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.437 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 48.6 m -101.75 144.5 30.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 47.4 t -57.68 -53.79 54.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.803 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 52.64 79.96 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.463 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 1.1 m -134.37 147.67 50.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.906 0.384 . . . . 0.0 110.867 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.6 m -126.27 142.25 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.866 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 141.57 135.82 3.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.495 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -123.76 131.44 53.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.913 0.387 . . . . 0.0 110.923 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -144.79 160.64 46.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.571 0.701 . . . . 0.0 110.908 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.691 ' O ' HG23 ' A' ' 413' ' ' VAL . 54.0 Cg_endo -69.73 -166.32 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.661 2.24 . . . . 0.0 112.373 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -50.24 105.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.913 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 411' ' ' PRO . 95.1 t -107.25 114.17 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.166 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 9.0 t -52.03 130.7 30.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 74.0 p -95.23 25.16 4.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -122.75 -35.8 3.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 7.6 p -119.45 -40.79 2.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 106.99 43.78 1.36 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.453 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.11 134.38 55.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 413' ' ' VAL . . . -95.31 147.88 23.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -135.64 99.72 4.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.913 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.03 -30.88 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 22.5 mtm180 -81.07 174.43 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -120.93 25.97 9.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.2 m -125.53 -45.19 1.8 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -64.24 -27.86 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -70.43 -56.53 6.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.8 mt -51.71 -32.45 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.134 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.7 m -88.12 -25.03 23.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.647 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.3 t60 -72.48 -16.72 61.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.873 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -80.34 -23.44 40.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -62.09 -45.23 94.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.2 tt -57.9 -22.67 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.48 -65.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 42.1 p -51.92 -49.59 62.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.176 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -100.18 56.47 0.82 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.497 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -103.92 140.97 36.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.835 0.35 . . . . 0.0 110.893 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.5 p -83.67 76.67 9.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -147.35 68.1 0.38 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.516 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 94.87 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.639 2.226 . . . . 0.0 112.336 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 15.7 t -55.56 161.7 1.92 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.876 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.5 t -53.69 -30.24 42.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.866 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.107 -0.83 . . . . 0.0 112.503 179.993 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 88.1 p -173.31 147.9 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.886 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 47.7 m -145.16 145.17 31.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 80.28 110.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.447 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 16.1 p -93.74 153.26 18.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.927 0.394 . . . . 0.0 110.798 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 8.0 t -93.92 -67.76 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.865 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 171.53 -165.46 38.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.452 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -122.93 89.89 3.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.921 0.391 . . . . 0.0 110.877 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -73.95 160.65 81.33 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.592 0.711 . . . . 0.0 110.93 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.6 Cg_endo -69.77 -166.22 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -50.37 107.79 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 411' ' ' PRO . 83.2 t -108.26 116.08 50.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.121 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 25.8 t -52.1 127.02 20.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.846 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 22.5 p -95.24 25.96 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.172 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -121.88 -48.64 2.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.27 -26.44 8.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.29 81.98 1.51 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.49 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -151.21 124.75 8.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -87.96 141.83 28.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -134.58 103.24 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 60.6 mt -56.5 -37.15 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.152 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -78.24 162.94 26.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 39.6 tttm -110.18 31.65 5.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.2 p -126.49 -50.06 1.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.92 -27.66 68.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.842 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -70.46 -54.74 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 71.4 mt -53.72 -33.37 22.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.143 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 90.9 m -86.7 -25.1 24.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.655 ' O ' HG22 ' A' ' 433' ' ' ILE . 83.1 t60 -71.95 -17.22 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -80.21 -22.43 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -63.17 -44.75 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 430' ' ' HIS . 11.9 tt -58.13 -22.23 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -95.48 -62.37 1.31 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 64.2 p -52.7 -44.41 66.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.123 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -63.32 -84.29 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -76.98 132.13 38.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 110.867 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 1.4 m 54.49 47.21 23.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -155.29 169.04 33.21 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 116.84 4.74 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.9 p -72.41 123.74 23.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.837 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 16.3 p -114.17 55.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.83 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.488 -179.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 2.9 m -149.1 115.38 5.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.911 0.386 . . . . 0.0 110.887 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 3.4 m -95.54 161.35 14.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . -130.02 -152.26 7.45 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.489 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 16.9 p -138.87 168.54 19.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.868 0.366 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 4.4 t -89.36 96.88 10.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -179.56 89.43 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -53.12 114.68 1.54 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.873 0.368 . . . . 0.0 110.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -113.16 159.19 35.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.617 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.7 Cg_endo -69.78 -166.31 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.72 2.28 . . . . 0.0 112.317 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -50.46 109.44 0.31 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 411' ' ' PRO . 99.5 t -105.83 117.93 52.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 36.8 t -54.14 137.16 41.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.848 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 24.8 p -95.41 26.81 3.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -126.62 -40.18 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.864 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 8.2 p -117.5 -28.99 5.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.09 30.05 9.75 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -95.6 138.6 33.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.8 0.333 . . . . 0.0 110.895 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -92.1 141.7 28.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -127.77 90.53 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 76.9 mt -51.78 -29.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.122 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -85.89 164.38 17.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -111.36 28.24 8.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 5.2 m -128.68 -39.33 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.83 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -71.56 -28.14 63.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.836 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -72.1 -44.47 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.846 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 63.8 mt -65.42 -27.62 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.127 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 92.0 m -90.53 -25.07 20.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.123 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.54 -23.93 65.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -70.37 -24.86 63.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -64.9 -59.27 4.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . . . . . . . . . 12.6 tt -53.01 -28.42 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.149 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -77.0 -40.02 48.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.82 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 30.8 p -79.22 91.49 4.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.095 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -93.95 -179.38 38.78 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.02 97.56 5.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 10.5 p -127.67 50.25 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -153.17 68.16 0.31 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.466 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 135.21 29.88 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.709 2.273 . . . . 0.0 112.348 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 51.0 m -84.24 62.93 7.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 3.3 m -99.87 -55.19 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.853 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.117 -0.824 . . . . 0.0 112.461 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 1.6 m -85.31 97.11 9.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.852 0.358 . . . . 0.0 110.84 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 33.8 t -94.14 -31.3 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 104.73 -135.41 12.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 40.0 m -125.88 159.14 33.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.85 0.357 . . . . 0.0 110.862 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 41.7 m -141.07 -177.48 5.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 81.92 76.94 1.06 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.444 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -109.34 70.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.918 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.72 160.71 67.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 0.0 110.864 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.8 Cg_endo -69.75 -166.25 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.667 2.244 . . . . 0.0 112.41 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -50.26 104.86 0.08 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 411' ' ' PRO . 76.5 t -102.36 124.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 11.2 t -60.52 127.49 31.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.926 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 19.0 p -96.18 29.48 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.77 -47.11 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.74 -27.2 7.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 93.16 82.7 1.53 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.513 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -156.18 128.07 7.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -86.11 146.61 26.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -136.56 100.71 4.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 69.6 mt -57.27 -33.03 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -83.24 152.76 25.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -99.28 27.11 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 35.6 t -124.73 -49.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.826 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -59.28 -40.22 85.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -57.36 -54.44 46.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.83 -55.2 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 95.5 m -61.22 -25.56 67.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.169 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.65 ' O ' HG22 ' A' ' 433' ' ' ILE . 82.5 t60 -80.43 -17.61 51.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.863 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -79.71 -21.72 44.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -63.97 -44.92 91.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.1 tt -58.73 -21.54 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -95.69 -27.01 15.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.868 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 74.0 p -103.22 70.19 1.05 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.157 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 170.13 -100.92 0.16 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -100.64 155.85 17.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.369 . . . . 0.0 110.881 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 6.9 t 58.38 32.72 22.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.96 32.34 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 119.56 6.48 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.71 2.273 . . . . 0.0 112.314 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.4 p -149.42 172.56 14.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.807 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 1.1 m 52.26 50.58 18.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.862 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 CA-C-O 119.16 -0.8 . . . . 0.0 112.497 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 4.3 p -129.88 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 0.0 110.869 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 1.9 t -79.3 -28.09 42.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 103.79 146.21 15.96 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.501 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.5 p -87.2 85.28 7.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.905 0.383 . . . . 0.0 110.886 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 3.5 t -134.58 112.93 11.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.869 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . -135.11 149.43 19.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.483 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -101.49 87.48 3.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.876 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 27.1 mtpt -124.69 160.63 52.78 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.52 0.676 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.612 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.77 -166.3 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.661 2.241 . . . . 0.0 112.341 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -50.25 109.89 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.976 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 411' ' ' PRO . 63.7 t -105.64 124.32 60.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 4.4 t -60.15 127.45 31.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 43.9 p -95.33 25.2 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.19 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -124.09 -46.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 23.2 p -113.24 -27.25 8.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.846 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 90.41 78.86 1.35 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.539 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -151.63 132.49 14.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.784 0.326 . . . . 0.0 110.935 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -84.31 148.36 26.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.088 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.02 95.87 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 70.5 mt -56.84 -27.17 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.128 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -83.84 155.95 22.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.62 32.72 3.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.7 p -139.89 -45.17 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -61.16 -28.33 69.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -76.57 -55.21 5.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.7 mt -55.18 -32.5 28.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.406 HG23 HH11 ' A' ' 432' ' ' ARG . 91.9 m -84.66 -26.36 27.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.9 t60 -74.36 -17.96 60.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -76.82 -22.88 52.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . 0.406 HH11 HG23 ' A' ' 429' ' ' THR . 61.9 mtt180 -60.71 -46.74 89.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.928 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 430' ' ' HIS . 13.0 tt -60.43 -19.36 18.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -93.37 -61.55 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 67.0 p -59.55 97.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . -145.14 167.63 27.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.478 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -124.89 81.81 1.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 2.3 m -122.74 103.57 8.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 111.44 179.26 20.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.457 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 166.27 28.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.647 2.231 . . . . 0.0 112.366 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.7 p -64.55 132.02 48.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 49.1 m -119.89 160.79 21.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 119.132 -0.816 . . . . 0.0 112.475 -179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' SER . . . . . . . . . . . . . 31.1 p -136.48 -176.25 4.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.851 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 60.0 p -149.04 148.39 29.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.82 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLY . . . . . . . . . . . . . . . 151.54 68.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 32.1 t -97.98 97.13 8.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.846 0.355 . . . . 0.0 110.813 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' SER . . . . . . . . . . . . . 2.0 t -105.4 151.66 23.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' GLY . . . . . . . . . . . . . . . 133.35 118.66 1.93 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.497 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -108.59 116.02 31.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 110.892 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -91.45 160.66 36.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.544 0.687 . . . . 0.0 110.904 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' PRO . . . . . 0.588 ' O ' HG23 ' A' ' 413' ' ' VAL . 53.9 Cg_endo -69.79 -166.26 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -50.36 110.13 0.37 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 411' ' ' PRO . 70.4 t -104.84 131.82 53.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.11 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' CYS . . . . . . . . . . . . . 1.8 t -65.5 128.48 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' THR . . . . . . . . . . . . . 51.3 p -95.99 25.11 4.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -126.97 -44.91 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' CYS . . . . . . . . . . . . . 26.5 p -116.13 -26.88 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' GLY . . . . . . . . . . . . . . . 88.92 84.41 1.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -154.68 123.8 6.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.757 0.313 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ALA . . . . . . . . . . . . . . . -77.57 144.79 37.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -135.24 96.88 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.893 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ILE . . . . . . . . . . . . . 65.5 mt -56.57 -26.05 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.108 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -84.32 159.29 20.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.09 24.79 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 10.0 p -134.26 -44.4 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -60.46 -26.72 66.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -78.26 -56.34 4.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ILE . . . . . . . . . . . . . 69.6 mt -54.34 -30.2 20.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 93.6 m -85.13 -25.56 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' HIS . . . . . 0.692 ' O ' HG22 ' A' ' 433' ' ' ILE . 81.3 t60 -82.33 -18.23 42.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.835 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -78.52 -23.04 46.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -59.63 -45.49 91.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 430' ' ' HIS . 12.0 tt -57.29 -23.3 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.149 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -95.64 25.43 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.9 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' THR . . . . . . . . . . . . . 48.6 p -148.93 -173.16 4.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.142 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 68.14 91.52 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -138.24 157.95 45.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.891 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' SER . . . . . . . . . . . . . 31.1 m -82.44 63.16 6.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . -62.76 -71.63 0.79 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 174.15 9.89 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.688 2.258 . . . . 0.0 112.378 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 41.2 t -91.37 -38.96 12.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' SER . . . . . . . . . . . . . 4.0 p 55.84 27.45 10.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.861 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.487 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_